Research Report

26
Apr
2024
Xiaomi 2024 Investor Day: To Be Global Hardcore Technology Leader in the Decade Ahead
23
Apr
2024
AIGC Industry: More products to come; Embracing multimodal LLM
23
Apr
2024
SPDBI Monthly Macro Insights: China’s Q1 growth is better than expected, and the possibility of substantial policy stimulus declines
22
Apr
2024
Proya (603605.CH): Multi-brands create multi-growth drivers, and high growth may sustain in 2024
22
Apr
2024
China Feihe (6186.HK): Channel management optimization increases investment value, high dividend payout elevates long-term shareholder investment return; upgrade to BUY
22
Apr
2024
TSMC 1Q24 earnings: 2024 guidance remains unchanged, and AI demand stays strong
22
Apr
2024
XPeng and Volkswagen joined hands again to develop E/E Architecture, deepening and speeding up the technical collaboration
17
Apr
2024
Q1 growth much better than expected, while the majority of March’s real activities data weaker than expected
15
Apr
2024
SPDBI Strategy Insights: New guidelines for capital market development released, high-dividend SOEs may be the beneficiaries
15
Apr
2024
Unity (U.US): Game engine leader expanding business boundaries and riding the GenAI wave
15
Apr
2024
SPDBI Monthly Strategy: Targeting opportunities in China market
15
Apr
2024
Topsports (6110.HK): Low PE, high dividend yield and sound fundamentals enhance its defensive support
11
Apr
2024
Takeaways from March’s inflation data and FOMC minutes: policy rate cut may be delayed to Q3
10
Apr
2024
Tongcheng Travel (780.HK): Tourism thrives during Qingming Holiday
10
Apr
2024
Sino Biopharmaceutical (1177.HK):BI strategic partnership kicks off, bringing more R&D assets to domestic oncology pipeline
10
Apr
2024
Super Hi (9658.HK):Strong 2023 result and optimistic 2024 outlook, unleashing growth potential
09
Apr
2024
RemeGen (9995.HK): No clear guidance for the out-licensing timeline of telitacicept, downgrade to hold rating
09
Apr
2024
Monthly fund flows: stocks southbound preferred to watch
08
Apr
2024
MicroPort NeuroTech (2172.HK): 2024 net profit is expected to achieve high growth due to steady revenue growth and reduction in expense ratio
05
Apr
2024
Huitongda (9878.HK): Business optimization; focus on profit improvement

More

05
Apr
2024
MedBot (2252.HK): Approval of medical equipment license may accelerate; keep an eye on cash management
05
Apr
2024
Sino Biopharmaceutical (1177.HK): Innovative drugs to drive 2024 revenue reaching double-digit growth
03
Apr
2024
Pharmaron (3759.HK/300759.CH):4Q23 results in line; 2024 revenue guidance being 10%+ YoY growth
03
Apr
2024
Vipshop (VIPS.US): Seasonal growth may be affected by weather; margins expected to improve
03
Apr
2024
NetDragon (777.HK): Games Remain Stable; exploring education software 3usiness
03
Apr
2024
Douyu (DOYU.US): Profitability improved; competitive pressure remains
03
Apr
2024
Huya (HUYA.US): Full-year turnaround; enhancing shareholder returns
02
Apr
2024
Xiaomi SU7 launch event and visit to Xiaomi Automobile Super Factory
02
Apr
2024
Yunkang Group (2325.HK): 2023 results under pressure due to faded COVID-19 tests demand and receivables impairment; routine testing revenue +27% YoY
02
Apr
2024
BYD (1211.HK/002594.CH): Sales volume to grow steadily on stabilized market expectations
02
Apr
2024
BYDE (285.HK): Sustainable increments from consolidated business, and high growth in auto electronics segment
02
Apr
2024
Keymed (2162.HK): 2023 net loss in 2023 higher than expected; CM310 guided RMB500mn sales target for 2025
02
Apr
2024
Mengniu Dairy (2319.HK): Fundamentals remain solid, but management changes may cause short-term market sentiment fluctuations
02
Apr
2024
WuXi Biologics (2269.HK): 2024 revenue guidance of 5%-10% YoY growth, lower than expected
28
Mar
2024
Giant Biogene (2367.HK): Brand strategy and online channel adjustment to drive rapid growth in 2024
28
Mar
2024
ANTA Sports (2020.HK): Operational quality improvement drives high-quality growth in 2024; maintain BUY rating
28
Mar
2024
SPDBI Monthly Macro Insights: Will soft landing scenario expected by US Fed be achieved?
28
Mar
2024
Leapmotor (9863.HK): Gross margin improved significantly in 4Q23 and sales growth to be achieved in both domestic and overseas markets
26
Mar
2024
Jiumaojiu (9922.HK): Bullish on long-term operation improvements despite the weak short-term trend priced in valuation
26
Mar
2024
AAC (2018.HK): We expect both revenue and profit growth in 2024, and auto acoustics drives long-term growth
26
Mar
2024
Meituan (3690.HK): Steady recovery in core business; focus on profit improvement
25
Mar
2024
China Mobile: AI, computing power, and new quality productive forces drive the company’s growth and lead technological innovation
25
Mar
2024
Li Auto (LI.US/2015.HK): Adjusted 1Q24 and full-year sales guidance promptly while continuing to improve operational efficiency
25
Mar
2024
Zylox Tonbridge (2190.HK): 2023 revenue growth slightly beats; Blood flow-guided mesh stent expected to be approved within the year
25
Mar
2024
US equity market series 4: Investing during the rate-cut cycle and AI revolution (I)
22
Mar
2024
XPeng (XPEV.US/9868.HK): Net loss narrowed in 4Q23 and NEV sales is expected to improve QoQ this year
22
Mar
2024
PDD Holdings (PDD.US): Topline and bottomline doubled; why not buy?
22
Mar
2024
Tencent (700.HK): Weak game performance; GPM keeps improving
22
Mar
2024
Kuaishou (1024.HK): First annual profit; Strong growth momentum in eCommerce
22
Mar
2024
Innovent Biologics (1801.HK): Operational efficiency driving net loss better than expected
22
Mar
2024
Xiaomi (1810.HK): Core business profit maintaining stable high profit and smart EV business valuation to be rerated
22
Mar
2024
Ping An Good Doctor (1833.HK): Organizational structure upgrade completed; gross profit margin improvement and cost saving help narrowing loss
22
Mar
2024
March FOMC meeting takeaways: Dovish Fed means policy rate cut may still start from Q2
21
Mar
2024
Li Ning (2331.HK): Reset channel inventory in 2023, rebuild brand and confidence in 2024, restart growth in 2025
21
Mar
2024
Tongcheng Travel (780.HK): Solid recovery; tourism to be the new topline driver
21
Mar
2024
Akeso (9926.HK): The Phase 3 interim analysis of Ivonescimab vs. Keytruda is expected to announce in end-2Q24
20
Mar
2024
SPDBI Monthly Macro Insights: Clarified economic growth target and policies to boost China’s economic recovery
20
Mar
2024
WuXi AppTec (2359.HK/603259.CH): 2024 topline/bottom line guided to decline slightly or remain flattish
20
Mar
2024
NVIDIA GTC 2024: Don’t miss this transformative moment in AI
19
Mar
2024
China Resources Beer (291.HK): One of the players with the strongest premiumization trend in 2024
19
Mar
2024
Takeaways from Jan-Feb real activities data: dual -track economic recovery continues
18
Mar
2024
NEV Industry Insights: Price competition remains fierce with battery cost reduction to benefit consumers
18
Mar
2024
China Healthcare Sector: Confidence in the long-term potential of innovative drugs, top pick Innovent and Akeso
15
Mar
2024
Luckin Coffee (LKNCY.US): Tradition breaker transformed to industry leader underpinned by strong innovation
15
Mar
2024
Pou Sheng (3813.HK): Channel mix and discount rate improvement may drive 2024 margin expansion
15
Mar
2024
What is the impact of large-scale equipment renewals and trade-ins of consumer goods?
14
Mar
2024
US CPI data remains resilient in February, but it may not impact on Fed’s rate cut decision
11
Mar
2024
Updates on Technology Industry: Broadly stable fundamentals, and market sentiment to be further repaired
11
Mar
2024
SPDBI Monthly Strategy: Earnings and the “Two Sessions” in focus
11
Mar
2024
Bilibili (9626.HK/BILI.US): Solid ad growth; targets breakeven in Q3
08
Mar
2024
JD.com (9618.HK/JD.US): Dividend and buyback impressive; recovery remains weak
07
Mar
2024
AIGC Investment Handbook: AI Stocks (US Software) to watch
06
Mar
2024
SPDBI Strategy Insights: Investment opportunities from “Two Sessions”
05
Mar
2024
SPDBI Monthly Macro Insights: US economy to shift from soft landing to hard landing?
05
Mar
2024
BUD APAC (1876.HK): Better positioned in 2024, with higher-than-expected 4Q23 EBITDA growth
05
Mar
2024
Li Auto 2024 Spring Launch Event: High-voltage BEV model officially launched, starting a new product cycle
05
Mar
2024
MWC 2024 Recap: 5G-A Accelerates, and AI continues to empower the Internet of Everything
04
Mar
2024
BYDE (285.HK): Expected stable profit growth in 2024/2025 and clear long-term strategy
04
Mar
2024
NetEase (9999.HK/NTES.US): Eggy Party maintains lead; entering new games cycle
01
Mar
2024
HUTCHMED (HCM.US/13.HK): Fruquintinib sales beat with impressive US sales at initial launch
01
Mar
2024
Vipshop (VIPS.US): Earnings beats on seasonal demand; steady growth in FY24 expected
01
Mar
2024
Zai Lab (ZLAB.US/9688.HK): Better-than-expected efgartigimod sales
28
Feb
2024
BeiGene (BGNE.US/6160.HK/688235.CH): Accelerated globalization progress, US surpassing China becoming the No.1 product sales contributor
28
Feb
2024
Li Auto (LI.US/2015.HK): Significantly improved net profits on YoY basis in 4Q23, first-achieved full-year turnaround, and annual sales target of 650k-800k in 2024
28
Feb
2024
SPDBI Monthly Fund Flows: Stock connect flows are positive, with a focus on high dividend stocks
27
Feb
2024
Transsion (688036.CH): 4Q23 high yoy growth in smartphone shipments and profits
26
Feb
2024
HUTCHMED (HCM.US/13.HK): A pioneer in small molecule targeted drugs, Syk inhibitor approval expected in 2024
26
Feb
2024
BeiGene (BGNE.US/6160.HK/688235.CH): Globalization progressing well
26
Feb
2024
Zai Lab (ZLAB.US/9688.HK): Accelerated commercialization progress pushing forward profitability; maintain BUY
26
Feb
2024
NVIDIA: FY4Q24 results and FY1Q25 guidance exceed expectations, and AI demand remains strong
22
Feb
2024
AIGC Industry Trend: Sora, a game changer in multimodal AI
22
Feb
2024
Global smartphone shipments in 4Q23 resumed yoy growth, and we maintain a moderate growth forecast for 2024 shipments
21
Feb
2024
4Q23 Hang Seng Indices rebalancing: limited market implications but presents stocks opportunities
09
Feb
2024
Alibaba (9988.HK/BABA.US): Lackluster performance in core e-commerce, downgrade to Hold rating
08
Feb
2024
Yum China (YUMC.US/9987.HK): Relatively positive outlook for ticket size and profit margin will boost market confidence in the new normal
08
Feb
2024
China foundry industry: 2024 fundamentals continue to improve
05
Feb
2024
SPDBI Monthly Strategy: Renewed focus on high-quality SOEs
05
Feb
2024
Technology field research: Movements in capital amplified the market sentiment while fundamentals stabilize
05
Feb
2024
Meituan (3690.HK): Intensifying competition in in-store business, downgrade to Hold rating
05
Feb
2024
SPDBI Monthly Macro Insights: Policies are pivotal for economic outlook
05
Feb
2024
January’s FOMC meeting almost rule out the possibility of March’s rate cut, the first rate cut could be in May
01
Feb
2024
JD.com (9618.HK/JD.US): Sluggish growth with bottom-line pressure, downgrade to Hold rating
30
Jan
2024
Haidilao (6862.HK): Recovery of table turnover rate is better than peers, but profit margin may miss market expectations
30
Jan
2024
SPDBI Monthly Fund Flows: A wave of buybacks may enhance liquidity
30
Jan
2024
NetEase (9999.HK/NTES.US): Improving visibility in regulation, maintain NetEase as sector top pick
30
Jan
2024
Tesla (TSLA.US): Slightly lower GM on a QoQ basis in 4Q23, and potentially slower volume growth in 2024
26
Jan
2024
SPDBI Strategy Insights: More supportive policies may boost market sentiment
25
Jan
2024
The PBoC announces 50 bps RRR cut, implying monetary easing to continue
25
Jan
2024
Tsingtao Brewery (168.HK/600600.CH): Resistance to premiumization increases amid consumption divergence; downgrade Tsingtao Brewery H shares to "Hold"
23
Jan
2024
Li Ning (2331.HK): 2024 results face high uncertainty; moderately reduce 2024-2025E forecast
23
Jan
2024
TSMC’s implications for 2024: Semiconductor foundries to return to growth, backed by strong Al demand
19
Jan
2024
SPDBI Quant Strategy: Introducing our A-share sentiment index (Ⅱ)
18
Jan
2024
4Q23 growth slightly lower than expected, while December’s data starts to show policy effect
18
Jan
2024
China Dairy Industry: Fundamentals remain robust, and valuation is significantly undervalued in the new normal
17
Jan
2024
CES 2024 recap: AI accelerates the innovation of many industries
15
Jan
2024
US inflation data continues to strengthen in December, lowering the likelihood of March Fed rate cut
15
Jan
2024
China Resources Beer (291.HK): Heineken will continue to drive premiumization, but at a slower pace
15
Jan
2024
SPDBI Quant Strategy: Introducing our A-share sentiment index (Ⅰ)
15
Jan
2024
Giant Biogene (2367.HK): Continued online business expansion boosts 2023 earnings to beat market expectation
10
Jan
2024
SPDBI Monthly Strategy: The best defense is a good offense
08
Jan
2024
ANTA Sports (2020.HK): Higher-than-peers performance visibility, and Amer Sports’ IPO to be finalized
08
Jan
2024
SPDBI Monthly Macro Insights: Waiting for the good news
03
Jan
2024
Li Ning(2331.HK):2023 net profit that may miss market expectations causes short-term pressure on stock price, but we still see a favorable 2024 outlook on fundamental recovery and stock price resilience
03
Jan
2024
2024 Outlook: Breaking the ice
18
Dec
2023
Topsports (6110.HK): Steady and high-quality 3QFY24 sales growth may boost market confidence
18
Dec
2023
Comments on China’s November economic data: Sluggish demand weakens the recovery momentum
18
Dec
2023
NEV 2024 Outlook: Maintaining high growth amid continued competition in incremental market
15
Dec
2023
Joint interpretation on the US Fed’s rate cut expectations: How to trade?
15
Dec
2023
Technology 2024 Outlook: End-user demand returning to growth, providing momentum for consumer electronics and Semi industries
15
Dec
2023
US Fed tone turns more dovish, are the policy rate cuts coming?
15
Dec
2023
SPDBI Strategy Insights: Market implications from the CEWC
15
Dec
2023
Internet 2024 Outlook: Growth or Value?
15
Dec
2023
Takeaways from Central Economic Work Conference: Modest policy stimulus under high quality growth requirement
15
Dec
2023
The rebound of US sequentia CPI suggests too early to say policy rate cuts
15
Dec
2023
Healthcare 2024 Outlook: Rise amid volatility; capture sub-sector rotation opportunities
15
Dec
2023
Consumer 2024 Outlook:Unearthing new opportunities in the new normal from the bottom up
12
Dec
2023
China Beauty Industry: Breaking through challenges, how can Chinese companies achieve sustainable growth?
08
Dec
2023
New Energy Vehicle Investment Handbook: China’s NEV industry in full bloom
08
Dec
2023
2024 China Strategy Outlook: Rejuvenation and growth beyond cycles
01
Dec
2023
2024 Economic Outlook: The mismatch of US and China economic cycle to enter into the second half
01
Dec
2023
Bilibili (9626.HK/BILI.US):DAU reaching 100mn; GPM improving
30
Nov
2023
APT Medical(688617.CH): Focus on three key cardiovascular segments; a bright future ahead
30
Nov
2023
Meituan (3690.HK): Inline revenue, bottomline under pressure
30
Nov
2023
BUD APAC (1876.HK): Positive trends in China and marginal improvement in South Korea will substantially increase earnings visibility; Upgrade to BUY
30
Nov
2023
PDD Holdings (PDD.US): Solid beat driven by Temu; GPM decline on revenue mix
28
Nov
2023
Takeaway of field trip to 2023 Guangzhou International Automobile Exhibition: Automation, premiumization, and intellectualization
28
Nov
2023
Technology field research: Takeaway from Transsion Holdings 2023 Investor Day
28
Nov
2023
Zylox Tonbridge (2190.HK): Neurointervention and peripheral intervention the two core segments; product approvals accelerate
23
Nov
2023
Kingsoft (3888.HK): Decent topline growth; mobile JX III to launch in 1H24
23
Nov
2023
Kuaishou (1024.HK): 3Q earnings beat; solid GMV growth
23
Nov
2023
Tongcheng Travel (780.HK): Strong growth momentum; outbound travel still in recovery
21
Nov
2023
China foundry industry: Industry margin and revenue growth rate are bottoming out, and the cycle is trending up
21
Nov
2023
SPDBI Trading Strategy: 3Q23 Hang Seng Indices rebalancing
20
Nov
2023
NetEase (9999.HK/NTES.US): Earnings beat; solid game pipeline
20
Nov
2023
Alibaba (9988.HK/BABA.US) : Inline results; cloud spinoff called off; lower TP
20
Nov
2023
JD.com (9618.HK/JD.US): Weak topline growth while bottomline beat
20
Nov
2023
MicroPort EP MedTech (688351.CH): Domestic electrophysiology leader; TrueForce and other new products drive earnings growth
20
Nov
2023
Tencent (700.HK): Inline revenue with improving GPM
16
Nov
2023
Vipshop (VIPS.US): Steady earnings recovery; focus on profit margin improvement; guidance remains cautious
16
Nov
2023
Sea (SE.US): Ecommerce in growth dilemma in short term; downgrade to Hold rating
16
Nov
2023
Comments on China’s October economic data: Uneven economic recovery continues, while momentum softens
16
Nov
2023
US inflation data slows more than expected in October, the rate hike cycle may have ended
15
Nov
2023
China Sportswear: Recent Xtep’s inventory crisis does not negatively imply same issue for Li Ning or ANTA
13
Nov
2023
Optics Industry Update: Flowers blooming and falling (Ⅱ)
13
Nov
2023
SPDBI Monthly Strategy: Style rotation underway
09
Nov
2023
Trend of profit growth improvement confirmed, focus on high-yield growth stocks
09
Nov
2023
SPDBI Monthly Macro Insights: Entering into a better stage
06
Nov
2023
Li Ning (2331.HK): Analysis of the growth drivers of Li Ning in different time dimensions
03
Nov
2023
BYD (1211.HK/002594.CH): Profit per car hit a record high in 3Q23
03
Nov
2023
MicroPort NeuroTech (2172.HK): Domestic leader with both growth potential and visibility, centralized procurement and new products drive earnings growth
02
Nov
2023
US Fed paused rate hike again in November, has the hike cycle ended?
02
Nov
2023
Yum China (YUMC.US/9987.HK): Market is overreacting, but long-term growth logic remains intact
02
Nov
2023
Mindray (300760.CH): 3Q23 revenue growth hindered by healthcare anti-corruption; improvements in gross profit margin and expense drive steady profit growth
02
Nov
2023
SPDBI Monthly Fund Flows: State-owned fund increasing holdings may boost market sentiment
02
Nov
2023
Yili (600887.CH): Main business steadily improving and 2023 net profit margin expected to surpass the guidance
02
Nov
2023
BUD APAC (1876.HK): Premiumization trend improving in China but Korea business faces great uncertainty in short term
02
Nov
2023
WuXi AppTec (2359.HK/603259.CH): 3Q23 results slightly lower than expected; the company lowered its full-year revenue guidance
02
Nov
2023
Pharmaron (3759.HK/300759.CH): 3Q23 results hindered by weak financing environment; the company maintains full-year revenue growth guidance
31
Oct
2023
Milkground(600882.CH):No sign of improvement on revenue , gross profit margin under pressure, but operational efficiency has improved
31
Oct
2023
Tsingtao Brewery (168.HK/600600.CH): The negative climate impact on sales has been absorbed, the structural upgrade exceeds market expectations
30
Oct
2023
Introducing Stellantis as a shareholder, Leapmotor opens up its overseas sales network for a win-win situation
27
Oct
2023
Times Electric (3898.HK/688187.HK): 3Q23 GM improvement drove up profit, with both rail transit business and emerging equipment business contributing increamental profit
26
Oct
2023
Wingtech (600745.CH): 3Q profit increased QoQ, with Nexperia's profit stablizing and ODM profit gradually releasing
26
Oct
2023
Li Ning (2331.HK): Decisive actions required under current situation to reorganize for next year’s performance
25
Oct
2023
XPENG 2023 Tech Day: Implementation of City NGP is coming soon
25
Oct
2023
Yangjie (300373.CH): 3Q23 GPM and operating profit recovered QoQ, indicating semi cycle bottoming out
25
Oct
2023
Luxshare (002475.CH): Profit growth sustaining in 3Q23 and 4Q23 with clear long-term growth path
24
Oct
2023
Topsports (6110.HK): Why we are bullish on Topsports’ stock performance for the next 12 months
24
Oct
2023
SPDBI Strategy Insights: Buying the dip of high quality stocks
20
Oct
2023
Read on U.S. new regulations on chips and semi equipment export control
20
Oct
2023
Kuaishou (1024.HK): Expect inline 3Q results, strong growth momentum in eCommerce
20
Oct
2023
Tesla (TSLA.US): Broadly stable GM on QoQ basis in 3Q23, increasing OPEX due to new product and technical inputs, and sustaining annual sales target of 1.8 million units
20
Oct
2023
US equity market series 3: Earnings the key driver
19
Oct
2023
BYD (1211.HK/002594.CH): 3Q23 preliminary results beat expectation, and profit per car continues growing
19
Oct
2023
BYDE (285.HK): 3Q23 positive profit alert beats expectation
19
Oct
2023
3Q growth better than expected, policy to shift to “wait and see” mode
19
Oct
2023
ANTA Sports (2020.HK): Multi-brand strategy establishes Anta’s core competitiveness, market confidence in Anta brand will likely increase
17
Oct
2023
iDreamSky (1119.HK): Decent performance in key titles, new game largely inline
16
Oct
2023
Transsion (688036.CH): Smartphone shipments return to growth, and software services provide long-term increments
16
Oct
2023
US core CPI inflation went up again in MoM term; it may be earlier to say that the Fed rate hike has been ended
16
Oct
2023
ANTA Sports (2020.HK): 3Q23 retail sales in line, 2023 profit growth may exceed expectation
10
Oct
2023
SPDBI Monthly Strategy: A balance of offense and defense
10
Oct
2023
Comments on National Day Golden Week’s data: Tourism performance to support consumption recovery
03
Oct
2023
BYDE (285.HK): Acquisition of Jabil’s assets expected to provide short-term and long-term profit increments
28
Sep
2023
SPDBI Monthly Fund Flows: Outflows slowed, inflows may return
27
Sep
2023
SPDBI Monthly Macro Insights: China’s policies come through, the expectation of US rate cut declines sharply
27
Sep
2023
Technology field research: Stable trends in Smartphone and NEV industries, bottoming out in semiconductor industry fundamentals
27
Sep
2023
China Power Semiconductor Industry: Wind power, photovoltaic, vehicle, storage and other new energy demands provide long-term increments, and cycle bottoms out in near future, opening up the upside
22
Sep
2023
Kuaishou(1024.HK):Improving content and monetisation ecosystem
22
Sep
2023
US Fed hints one more rate hike this year, while high interest rate may persist longer
19
Sep
2023
US equity market series 2: Asset allocation after rate hikes
18
Sep
2023
With a second RRR cut this year and largely better-than-expected real activities data, what is the next step for policies?
15
Sep
2023
US core CPI in MoM term rebounded in August, expecting another rate hike in 4Q
15
Sep
2023
Apple Event 2023: iPhone 15 continues steady upgrade path
14
Sep
2023
Alibaba (9988.HK/BABA.US): Leadership transition completed—new changes and new expectations
14
Sep
2023
Macro theme research: What is the economic impact of old village renovation?
14
Sep
2023
Star Plus Legend (6683.HK): Innovative new retail player empowered by celebrity IP
12
Sep
2023
China Gaming Industry: Recovering with new trends
11
Sep
2023
Li Ning (2331.HK): Steady positive sell-through with slower market sentiment improvement
11
Sep
2023
SPDBI Monthly Strategy: New measures provide opportunities in the China market
11
Sep
2023
Topsports (6110.HK): 1HFY24 sales is expected to steadily recover compared with pre-pandemic level, with strong visibility of net profit margin expansion
07
Sep
2023
Smartphone Industry Watch: HUAWEI Kirin returns while Apple’s new releases approaching
07
Sep
2023
Yunkang Group (2325.HK): COVID receivables are collected steadily; short-term performance is disrupted by COVID, positive in long-term potential
07
Sep
2023
Super Hi (9658.HK): Negative catalyst observation — slower than expected store opening pace may lead to weak short-term stock price
07
Sep
2023
Tsingtao Brewery (168.HK/600600.CH): With peak season ending soon, short-term weak sales volume may affect market sentiment
07
Sep
2023
Venus MedTech (2500.HK): Domestic business emphasizes profitability, with subsidy decreased in 1H23; rapidly expand overseas markets through Venus-P
07
Sep
2023
Peijia Medical (9996.HK): TAVR market share continued to increase in 1H23, growth of neurointerventional products slightly exceeded expectations
07
Sep
2023
MicroPort CardioFlow (2160.HK): 1H23 implantation volume in-line, August performance is slightly affected by the medical anti-corruption
05
Sep
2023
Technology industry interim results summary: Market demand of smartphone and NEV is still the most important fundamental support
05
Sep
2023
MedBot (2252.HK): 1H23 Toumai installation lower than expected; short-term focus should be impact of medical anti-corruption and liquidity
05
Sep
2023
SPDBI Strategy Insights: Three investment strategies on easing mortgage policies
04
Sep
2023
SPDBI Monthly Macro Insights: China to wait for further policy support, US Fed’s rate hike cycle to continue
04
Sep
2023
Three arrows from the PBoC to stabilize property sector, what’s the implication?
04
Sep
2023
Mengniu Dairy (2319.HK): High 2H23 OPM base with strong visibility for long-term margin growth
04
Sep
2023
iDreamSky (1119.HK): Cost reduction leads to turnaround, new games expected to be growth driver
04
Sep
2023
Mindray (300760.CH): Stable 1H23 results in-line;impact of anti-corruption gradually appears in 3Q23
31
Aug
2023
Huitongda(9878.HK): Performance remains resilient, growth expected to pick up in 2H23
31
Aug
2023
Haidilao (6862.HK): 1H23 results in line with expectations, but guidance is mixed
31
Aug
2023
Pinduoduo (PDD.US): Revenue growth accelerated again and greatly exceeded expectations, even as margins declined
31
Aug
2023
China Feihe (6186.HK): Digital ecology has positive meaning in the long term, but is unlikely to change short-term structural difficulty
31
Aug
2023
Yili (600887.CH): High 2023 earnings visibility but weak short-term market sentiment
31
Aug
2023
BYDE (285.HK): Gross margin improved significantly in Q2, with multiple businesses driving up fundamentals
31
Aug
2023
BYD (1211.HK/002594.CH): Profit per car grew in Q2, and BYD maintained the annual sales target of 3 million units
30
Aug
2023
Tongcheng Travel (780.HK): Strong third-quarter earnings growth expected during peak travel season
30
Aug
2023
SPDBI Monthly Fund Flows: Oversold high-quality stocks to watch
30
Aug
2023
Pharmaron (3759.HK/300759.CH): Mature business grows steadily in 1H23; CMC business inquiry volume recovers since June
29
Aug
2023
SPDBI Strategy Insights: Measures to revive stock market may boost market confidence
29
Aug
2023
Wingtech (600745.CH):Overseas automotive business stabilizes Nexperia’s profitability, while cost control drives loss reduction in ODM segment
28
Aug
2023
iDreamSky (1119.HK): Self-developed games enter harvest season, Fanbook helps long-term operation of Games
28
Aug
2023
Meituan (3690.HK): GPM improvement drives profit beat; food delivery expected to slow, and hotel & travel expected to remain strong in Q3
28
Aug
2023
WuXi Biologics (2269.HK): 1H23 adjusted net profit growth lower than expected; new projects recovered significantly in June
25
Aug
2023
Optics Industry: Flowers blooming and falling (Sunny and Q-Tech 1H23 earnings results read)
25
Aug
2023
Jiumaojiu (9922.HK): 2023 store net open target in line with expectation, store level operation continues to recover
23
Aug
2023
ANTA Sports (2020.HK): Multi-brands and high proportion of direct retail business boost strong earnings, profit growth may further accelerate in 2H23
22
Aug
2023
SPDBI Trading Strategy: 2Q23 Hang Seng Indices rebalancing
22
Aug
2023
Kingdee (268.HK): Adjust 2023-25E estimates, maintain BUY
22
Aug
2023
Yonyou (600588.CH): Adjust 2023-25E estimates, maintain BUY
22
Aug
2023
Vipshop (VIPS.US): Adjust 2023-25E estimates, maintain Hold
21
Aug
2023
Global smartphone shipments YoY decline narrows in 2Q23, and we expect a moderate demand recovery in 2H23
21
Aug
2023
China Resources Beer (291.HK): High earnings visibility for 2023, and strong premiumization trend in long term
21
Aug
2023
Bilibili (9626.HK/BILI.US): Ad monetization accelerating, delays in new games lead to lower revenue guidance
21
Aug
2023
JD.com (9618.HK/JD.US): Earnings exceed expectation, subsidies lead to margin decline
21
Aug
2023
Tencent (700.HK): Seasonal fluctuation in domestic gaming, video accounts drive strong recovery in ad business
21
Aug
2023
Chongqing Brewery (600132.CH): Valuation elasticity shown as expected, and market sentiment expected to improve further
18
Aug
2023
Weimob (2013.HK): Adjust 2023-25E estimates, maintain BUY
18
Aug
2023
Sea (SE.US):Gaming bottom out, e-commerce miss
18
Aug
2023
Will Semiconductor (603501.CH): Adjust 2023-2025E earnings forecasts and target price, and maintain BUY rating
15
Aug
2023
US executive order of restrictions on investment in China: Limited short-term impact, long-term focus on technological competition
15
Aug
2023
Pou Sheng (3813.HK): Optimistic about revenues, but margins under pressure in short term; lower TP, maintain BUY rating
15
Aug
2023
China Semiconductor Foundry: Read on 2Q23 earnings results in the cycle switching
14
Aug
2023
Alibaba (9988.HK/BABA.US): Core e-ommerce turnaround
14
Aug
2023
Li Ning (2331.HK): Improved full-year result visibility, short-term valuation expected to increase; maintain BUY
14
Aug
2023
July US inflation data to support the Fed to skip rate hike in Sep, but may not mean the end of hiking cycle
11
Aug
2023
US equity market series 1: A shifting stock-bond correction
11
Aug
2023
Li Auto (LI.US/2015.HK): 2Q23 significant earnings growth, 3Q23 soft delivery guidance limited by capacity, 4Q23 delivery expected to increase driven by new capacity release
09
Aug
2023
July inflation data comments: Details better than headline print, more policy effort is still needed
09
Aug
2023
Technology field research: Takeaways from Wingtech’s Kunming factory visit
07
Aug
2023
Exploring consumer electronics from Apple: CY2Q23 results and CY3Q23 gross margin guidance beat expectation with strong performance on iPhone switching and wearables in China
07
Aug
2023
HUTCHMED(13.HK/HCM.US): 1H23 results in-line; Fruquintinib expected FDA approval by year-end
07
Aug
2023
SPDBI Monthly Strategy: The best is yet to come
07
Aug
2023
BUD APAC (1876.HK): Short-term margins under pressure, mid- to long-term growth logic weak; maintain Hold
03
Aug
2023
PBoC mid-year work conference takeaways: What to expect from monetary policy in 2H23?
02
Aug
2023
Yum China (YUMC.US/9987.HK): Same-store sales recovery and store expansion boost revenue growth
02
Aug
2023
WuXi AppTec (2359.HK/603259.CH): 1H23 profit growth slightly beats;High growth in non-COVID business
01
Aug
2023
China Catering Industry: How to pick winners in the most competitive consumer sub-sector?
01
Aug
2023
SPDBI Monthly Macro Insights: China’s economic outlook after Politburo meeting, US seeing soft landing scenario
27
Jul
2023
Volkswagen takes stake in Xpeng, laying the foundation of long-term strategic cooperation and opening up a win-win situation
27
Jul
2023
Fed raises policy rate by 25bps in July, which might not be the end of hike cycle
25
Jul
2023
Takeaways on the July Politburo meeting: Give more priority to preventing and resolving risks
25
Jul
2023
SPDBI Strategy Insights: July Politburo meeting reaffirms three key investment strategies
21
Jul
2023
Tesla (TSLA.US): 2Q23 GM slightly below expectations, maintained annual deliveries target of 1.8 million
21
Jul
2023
Exploring semiconductor industry from TSMC: fundamentals in the downcycle while AI demand grows rapidly
21
Jul
2023
Kuaishou (1024.HK): Q2 results expected to remain solid, profits may exceed expectations
21
Jul
2023
Ping An Good Doctor (1833.HK) – 1H23 results preview: Revenue under pressure due to strategic transformation, 2024E may return to revenue growth
21
Jul
2023
Sunny Optical (2382.HK): Profit warning fully eases performance risks
21
Jul
2023
Takeaways on Central Government’s new policies to support private economy
21
Jul
2023
SPDBI quantitative views: The Hong Kong market volatility is going down
19
Jul
2023
China unveils new plan to boost household consumption, while more policy support is still needed to expand domestic demand
18
Jul
2023
Will Semiconductor (603501.CH): Preliminary earnings factoring in fundamentals weakness in 1H23, expecting fundamentals and valuations to trend up in 2H23
18
Jul
2023
BYD (1211.HK/002594.CH): 2Q23 preliminary results beat expectation, optimistic about the growth momentum of NEV
18
Jul
2023
BYDE (285.HK): 2Q23 positive profit alert beats expectation, multiple business segments keep boosting fundamentals
18
Jul
2023
China cheese industry: Demand may be experiencing structural challenges
18
Jul
2023
Semiconductor memory trends in the age of large-scale AI models from Huawei’s AI memory product launch
14
Jul
2023
Exploring smartphone optics industry from Largan: Industry demand gradually stabilizes
14
Jul
2023
SPDBI Strategy Insights: Capturing the resilience amid volatility
14
Jul
2023
Interpretation of symposium on platform economy: release of favorable policies to promote valuation improvement
14
Jul
2023
Faster-than-expected core CPI deceleration is less likely to avoid the July rate hike
12
Jul
2023
Messages from the extension of property financing support measures and the series of enterprise symposiums
12
Jul
2023
Technology field research: Improving visibility in trends of semiconductor and NEV industries
12
Jul
2023
AIGC industry trend: LLMs tend to diverge, focus on applications development
10
Jul
2023
Anta (2020.HK): 1H23 profit growth may lead the industry, expect higher growth in 2H23
10
Jul
2023
June FX reserves increased largely by FX valuation effect, expecting RMB to appreciate in mid-term
06
Jul
2023
SPDBI Strategy Insights: Investing through RMB cycles
06
Jul
2023
Li Ning (2331.HK): 1H23 margins face challenge, but 2H23 will rebound; maintain BUY
06
Jul
2023
June FOMC Minutes takeaway – At least two more rate hikes this year
05
Jul
2023
2H23 Outlook: Positives ahead
05
Jul
2023
Strategy 2H23 outlook: Sailing with the tailwind
05
Jul
2023
China Sportswear: 1H23 results set, 3Q23 revenue faces challenges
04
Jul
2023
Topsports (6110.HK): Growth potential holds for 2023, 2024 and beyond
29
Jun
2023
SPDBI Monthly Macro Insights: China to eye on stimulus, US to be wary of credit tightening
27
Jun
2023
Consumer 2H23 outlook:Be patient and rational, seek for growth visibility
27
Jun
2023
Internet 2H23 outlook: Could AIGC help the Internet industry overcome the “midlife crisis”?
27
Jun
2023
Technology 2H23 outlook: Having been waiting in 1H23 and to be waiting in 2H23 for industry fundamentals and valuations to resonate upward
27
Jun
2023
Healthcare 2H23 outlook: Buy stocks with elasticity and innovative nature; new catalysts are needed for sharp rebound
27
Jun
2023
New energy vehicle 2H23 outlook: Accelerating growth amid industry volatility
21
Jun
2023
Technology field research: Sunny 2023 Investor Day Observation
15
Jun
2023
New Energy Vehicle Investment Handbook: Riddles and thoughts on the prisoner’s dilemma
07
Jun
2023
China Semiconductor Foundry: valuation bottomed out ahead of fundamentals, taking advantage of Beta upside opportunity
06
Jun
2023
1Q23 global smartphone shipment slightly below expectation, waiting for marginal demand recovery in 2H23
06
Jun
2023
Shandong Weigao (1066.HK): Investor day emphasize on innovation; accelerate R&D in rehabilitation and informatization products apart from core pipeline
06
Jun
2023
2H23 Economic Outlook: US to enter recession gradually, China’s recovery story to resume
05
Jun
2023
Meituan (3690.HK): Earnings beat; intensifying competition in instore business
05
Jun
2023
Bilibili (BILI.US/9626.HK): Loss narrowing down; Ad recovery on track
31
May
2023
PDD Holdings (PDD.US): Solid 1Q result; overseas expansion continues
30
May
2023
Tongcheng Travel (780.HK): Booming travel demand
25
May
2023
Kingsoft (3888.HK): adjust 2023-25E estimates, maintain Buy
25
May
2023
Topsports (6110.HK): Fundamentals remain solid with high certainty of margin expansion
25
May
2023
Kuaishou (1024.HK): earnings beat; solid growth in eCommerce
23
May
2023
Technology field research: smartphone, NEV and foundry industries update and outlook
23
May
2023
Alibaba (9988.HK/BABA.US): inline result, expect positive FY1Q24 GMV growth
18
May
2023
Tencent (700.HK): earnings back on growth track in 1Q23, accelerated recovery expected
18
May
2023
Sea (SE.US): adjust 2023-25E estimate and price target, maintain BUY
16
May
2023
Weimob (2013.HK): adjust 2023-25E estimate and price target, maintain BUY
16
May
2023
Xiaomi (1810.HK): expect GPM improvement in 1Q23, maintain BUY
12
May
2023
Pou Sheng (3813.HK): excellent 1Q23 results and strong revenue growth in April and Labor Day Golden Week boost market confidence and improve market expectations, raise price target
12
May
2023
JD.COM (9618.HK/JD.US): 1Q23 profits beat; 3P is expected to be the new driver
12
May
2023
Topsports (6110.HK): Pou Sheng’s strong revenue growth in April and labor day golden week may boost Topsports’ stock performance
11
May
2023
Beer Industry in China: Increased product mix and decreased cost pressure
11
May
2023
Chongqing Brewery (600132.CH): Weaker earning guidance, but bullish on stock price flexibility in peak season
11
May
2023
Luxshare (002475.CH): 2Q23 earnings guidance beyond expected and counter-trend growth driven by multi-business expansion
11
May
2023
Budweiser Brewing APAC (1876.HK): The certainty of post-pandemic recovery trend of the Chinese and Korean markets may diverge
05
May
2023
Chongqing Brewery (600132.CH): Weaker earning guidance, but bullish on stock price flexibility in peak season
03
May
2023
Transsion (688036.CH): Handset shipments driven up by inventory replenishment, and focus on ChatGPT and AI strategies
03
May
2023
Yonyou Network (600588.CH): Adjust 2023-25E forecasts and target price, maintain Buy
03
May
2023
Ausnutria Dairy (1717.HK): Declining product mix hinders margin rebound, weak industry trend hampers valuation reversal; Cut TP and maintain Hold
03
May
2023
Inner Mongolia Yili (600887.CH): High certainty of organic margin expansion with Ausnutria being the biggest uncertainty
03
May
2023
Shenzhen Mindray (300760.CH): 2022 and 1Q23 results in line; IVD slightly dragged by Covid-19
03
May
2023
Pharmaron (3759.HK/300759.CH): Mature businesses showed resilience in 1Q23, while order book buildup from the new business is on track
03
May
2023
BYDE (285.HK): Increasing capacity utilization and high growth in automotive business
27
Apr
2023
Alibaba (9988.HK/BABA.US): Alibaba Cloud Slashes Prices to Bolster Market Dominance
27
Apr
2023
Technology Field Research: ICT industry trends seeing from Huawei
27
Apr
2023
WuXi AppTec (603259.CH/2359.HK): Slowdown in core business growth in 1Q23, cut price target
27
Apr
2023
Tsingtao Brewery (168.HK/600600.CH): Strong 1Q23 performance, follow-up focus on structural optimization sustainability; raise forecasts and price target
26
Apr
2023
Tesla (TSLA.US): Improving supply and demand balance, rapid growth of NEV sales, and fair valuation
25
Apr
2023
Bilibili (9626.HK/BILI.US): Ad recovery on track; key title in pipeline
21
Apr
2023
Will Semiconductor (603501.CH): Fundamentals improve quarter by quarter, resonating upwards in multiple sectors
19
Apr
2023
Antengene (6996.HK): Potentials of core product significantly undervalued; in-house R&D entering validation stage
19
Apr
2023
OTA sector in China: Booming demand in tourism
17
Apr
2023
Q Technology (1478.HK): Fundamentals bottoming out in 2H22 and to rebound in 2H23
13
Apr
2023
Venus MedTech (2500.HK): Implant volume slightly dropped in 2022; follow-up attention can be paid to the timing of profit breakeven and the progress of oversea commercialization
13
Apr
2023
ANTA Sports (2020.HK): Mixed short-term trends with certainty of long-term store efficiency recovery and margin expansion
13
Apr
2023
Sunny Optical (2382.HK): Vehicle related business continues to drive growth in group profit
13
Apr
2023
Sino Biopharmaceutical (1177.HK): Lowering the earnings forecast and target price for 2023-24E
06
Apr
2023
MicroPort CardioFlow (2160.HK): Non-recurring expense increase loss in 2022;strong recovery of the implant volume has already appeared in 1Q23
06
Apr
2023
Peijia Medical (9996.HK): Continue to reduce losses under 2022 COVID pandemic; market share of transcatheter valve and neurointerventional business are expected to further increase
06
Apr
2023
Everest Medicines (1952.HK): Domestic commercialization approaching, long-term value of core products significantly underestimated
06
Apr
2023
MedBot Surgical (2252.HK):2022 result is slightly lower than expected due to license restriction and COVID;short-term disturbances will not change long-term growth potential
04
Apr
2023
China Mengniu Dairy (2319.HK): High quality long term investment target with high certainty of profitability improvement and high valuation-to-cost ratio
04
Apr
2023
Nayuki (2150.HK): Optimized single-store model provides significantly improved profit outlook, and expansion pace further increases; upgrade to Buy
04
Apr
2023
Pharmaron (3759.HK/300759.CH): trimmed 2023-24E earnings estimates and target price
31
Mar
2023
RemeGen (9995.HK): Sales performance affected by COVID-19 but regaining momentum recently; global R&D on track
31
Mar
2023
Kuaishou (1024.HK): improving profitability outlook
31
Mar
2023
Huitongda (9878.HK): decent growth against headwind
31
Mar
2023
Xiaomi (1810.HK): Waiting for the smartphone industry to recover
31
Mar
2023
Topsports (6110.HK): Nike rebound drives revenue growth, inventory optimization drives margin expansion
31
Mar
2023
Innovent Biologics (1801.HK): Adjust upward the 2023-24E net loss forecast; lower the target price.
31
Mar
2023
Alibaba (9988.HK/BABA.US): restructuring favorable for long term valuation
31
Mar
2023
InnoCare Pharma (9969.HK): Impressive interim readout from orelabrutinib Phase II study in MS; commercial infrastructure ramping up
29
Mar
2023
Zhaoke Ophthalmology (6622.HK): Raised 2023-24E adjusted net loss forecast; lowered target price
27
Mar
2023
China Resources Beer (291.HK): Preminization accelerates, core EBIT continue to expand significantly; maintain top choice of the industry
27
Mar
2023
Meituan (3690.HK): Earnings beat;intensifying competition in in-store business
24
Mar
2023
WuXi Biologics (2269.HK): Strong growth momentum in core business to continue into FY23; mid-to-long term visibility improving
23
Mar
2023
Tencent (700.HK): Effective cost control; online-ad recovery on track
23
Mar
2023
WuXi AppTec (603259.CH/2359.HK): Expecting core business to record solid growth in 2023; new business gaining momentum
23
Mar
2023
Anta (2020.HK): In-line 2023 revenue guidance with margin expansion as the key driver
23
Mar
2023
Kingsoft (3888.HK): Adjusts 2023-25E forecast and target price, maintains Buy
23
Mar
2023
Trip.com (780.HK): Promising prospect for recovery, focus on increasing user ARPU
22
Mar
2023
Keymed Biosciences (2162.HK): Moderate cash burn in FY22, sales force ramp-up and advancement of early-stage R&D projects among key focuses in 2023
22
Mar
2023
Pinduoduo (PDD.US): investing more to bolster consumption and accelerating overseas expansion
21
Mar
2023
Kingdee International (268.HK): adjust 2023-25E estimates and price target, maintain Buy
21
Mar
2023
CStone Pharmaceuticals (2616.HK): cut 2023-24E estimate and target price
21
Mar
2023
Li Ning (2331.HK): Expect short-term negative sentiment with retail trend continues to improve; trim target price
17
Mar
2023
Pou Sheng International (3813.HK): Solid 4Q22 margins indicate improving operational Capabilities; maintain Buy
17
Mar
2023
Akesobio (9926.HK): First bispecific antibody delivered outstanding sales performance; multiple catalysts to watch for in 2023
17
Mar
2023
Ping An Good Doctor (1833.HK): New strategies start to bear fruit; business recovery and customer acquisition performance among key themes in 2023
17
Mar
2023
New valuation mode of HK equity market
17
Mar
2023
Zai Lab (ZLAB.US/9688.HK): Long-term pipeline potential significantly under-appreciated; initiate on ZLAB.US at Buy
17
Mar
2023
JD.com (9618.HK/JD.US): Better-than-expected profit improvement; refocus on low-price strategy
10
Mar
2023
China Sportswear: Adidas still faces big short-term challenges, but won’t affect its Chinese retail partners to rebound in 2023
10
Mar
2023
Sea (SE.US): Earnings beat; expect take rate to improve
07
Mar
2023
Bilibili (9626.HK/BILI.US): decent cost control, weak 2023 guidance
07
Mar
2023
Peijia Medical (9626.HK/BILI.US): Interventional medtech incubation platform unveiled, 2023 R&D Day highlights the depth of product pipeline
07
Mar
2023
Beigene (9626.HK/BILI.US): With strong FY22 results, BeiGene continues its evolution into a global big pharma
03
Mar
2023
Budweiser Brewing Co APAC (1876.HK): High certainty of revenue rebound, but EBITDA margin outlook still unclear; maintain Hold
02
Mar
2023
HUTCHMED(HCM.US/13.HK): Strong commercial performance delivered in FY22; core products further penetrated into target markets
02
Mar
2023
MicroPort CardioFlow (2160.HK): 2022 revenue in line; net loss increase partly due to non-cash and one-off items
01
Mar
2023
RemeGen (9995.HK): Amid rising competition among HER2 ADCs in China, Remegen holds advantages in safety profile and pricing
01
Mar
2023
Technology Field Research and Update on 2023 outlook: maintaining cautious and expecting to improve in 2H23 for smartphone industry; wait-and-see sentiment lingering and new models expected to drive growth in NEV industry
01
Mar
2023
Alibaba (9988.HK/BABA.US): earnings beat; expect gradual recovery
01
Mar
2023
Vipshop (VIPS.US): adjust 2023-24E estimates and target price; maintain Hold
27
Feb
2023
Keymed Biosciences (2162.HK): Global rights on Claudin 18.2 ADC out-licensed to AstraZeneca; Raise TP
23
Feb
2023
Tsingtao Brewery (168.HK/600600.CH): limited preminization but attractive valuation of H shares
23
Feb
2023
Milkground (600882.CH): challenging short term performance with solid long term growth logic; cut target price and maintain Buy
20
Feb
2023
InnoCare (9969.HK): regain its global rights to orelabrutinib for autoimmune diseases; cut target price
16
Feb
2023
Pou Sheng (3813.HK): Recovery of international sportswear brand under low base escalate Pou Sheng’s revenue growth; maintain Buy and target price
15
Feb
2023
AIGC, engine of new era
15
Feb
2023
China CXO review & outlook: Strong performance delivered by core business in 2022; keep an eye on structural changes within the sector
15
Feb
2023
Hong Kong equities: turn back to momentum driven market
09
Feb
2023
Meituan (3690.HK): Expect mild impact from Tiktok
09
Feb
2023
China’s beer industry: Premiumization accelerated 2023 revenue growth, but the outbreak will take time
09
Feb
2023
China Resources Beer (291.HK):Premiumization drives 2023 revenue growth and profit margin expansion, raise target price
09
Feb
2023
Zhaoke Ophthalmology (6622.HK): Development of low-dose atropine on track, significant room in stock rerating
09
Feb
2023
Nayuki (2150.HK):Improved profit outlook, but the resilience of store efficiency rebound may vary, raise target price while maintaining Hold
03
Feb
2023
Topsports (6110.HK): Fundamentals began to rebound, and market attention increased; raise target price and maintain Buy
03
Feb
2023
Beigene (6160.HK): growing market expansion potential for core products; raise target price
01
Feb
2023
Tongcheng Travel (780.HK):recovery on track
01
Feb
2023
Yili (600887.CH): Higher than expected CNY sales and high certainty for 4Q22 result. Adjusted 2022-24E estimates and raise TP
01
Feb
2023
Huitongda Network (9878.HK): Adjust 2022-24E estimates, maintain Buy and TP
31
Jan
2023
HUTCHMED (HCM.US/13.HK): Major process made in fruquintinib globalization, savolitinib negotiated into the NRDL
31
Jan
2023
Peijia Medical (9996.HK):adjust 2022-24E estimates and maintain TP
31
Jan
2023
Chongqing Brewery (600132.CH): Possibly the one beer company with the best resilience
16
Jan
2023
Mengniu (2319.HK): steady 2022 performance and bright future of 2023
16
Jan
2023
Anta (2020.HK): beyond expectation 4Q22 retail sales of anta brand, improving inventory sales rate of Fila and positive outlook of management will boost market confidence
16
Jan
2023
MedBot Surgical (2252.HK):Commercialization of Chinese surgical robot kicks off
16
Jan
2023
Transcatheter Heart Valve: Spring to come
11
Jan
2023
Li Ning (2331.HK):Expect higher than industry recovery rate; lower 2022 forecast and maintain 2023/2034 forecast, remain “buy” rating and raise TP
11
Jan
2023
Everest Medicines 1952.HK): New corporate strategies underway; build-out of in-house capabilities to drive long-term sustainable growth
21
Dec
2022
Anta (2020.HK): Future elasticity and certainty are greater than short-term turnover and profit margin pressure
20
Dec
2022
Alphamab Oncology (9966.HK): Latest clinical data of bispecific antibodies revealed at SABCS 2022, raise target price
16
Dec
2022
The "Strategic Plan for Expanding Domestic Demand" benefit long-term consumption power recovery and upgrading, but will take time to reveal result
12
Dec
2022
2023 Outlook: Awakening
12
Dec
2022
Macro 2023 outlook:A turning point
12
Dec
2022
Strategy 2023 outlook:Risk factor rotation
12
Dec
2022
Consumer 2023 outlook:zigzag recovery amid uncertainty
12
Dec
2022
Internet 2023 outlook: Improving visibility in recovery
12
Dec
2022
Technology 2023 outlook: Technology 2023 outlook: Waiting for smartphone industry fundamentals and valuations to resonate upward
12
Dec
2022
Healthcare 2023 outlook: Breaking dawn
12
Dec
2022
New energy vehicle 2023 outlook: NEV penetration continuing to accelerate upward
09
Dec
2022
Akeso (9926.HK): Blockbuster out-licensing deal validates the potential of Akeso’s bispecific pipeline, raise TP
09
Dec
2022
Mengniu (2319.HK) : market expectations and performance certainty deviates, valuation is expected to rise in short term
09
Dec
2022
Feihe (6186.HK): lower performance forecast for 2022-2024 and target price, maintain “hold” rating
01
Dec
2022
Topsports (6110.HK): The recovery of Nike brand power and stable inventory enhance the certainty of performance
01
Dec
2022
Bilibili (9626.HK/BILI.US): in-line result, efficient cost control
30
Nov
2022
Leapmotor (9863.HK) initiation: in-house electronic components manufacturing capability providing potential high profit growth
30
Nov
2022
Li Ning (2331.HK): 2022 guidance faces challenges, but healthy inventory level sets the ground for continuous development
30
Nov
2022
Pinduoduo (PDD.US): PDD: Solid 3Q22 result
28
Nov
2022
ZH-stocks under current investment style
28
Nov
2022
China biotech: We continue to like companies with good execution power, ample catalyst and attractive valuation
07
Nov
2022
Yili Group (600887.CH): Adjust 2022-24E earnings estimates and raise the target price
07
Nov
2022
Mindray (300760.CH): Adjust 2022-24E earnings estimates and raise the target price
07
Nov
2022
Overseas Power Semiconductor Series Takeaways
04
Nov
2022
Mengniu (2319.HK): High 2H22 performance certainty, optimistic about Mengniu’s short-term valuation recovery
03
Nov
2022
RemeGen (9995.HK): 3Q sales in line; watch for further sales ramp-up and clinical milestones
31
Oct
2022
Yili Group (600887.CH): Unsatisfactory 3Q22 performance does not change Yili’s stable long-term fundamentals
31
Oct
2022
Pharmaron (3759.HK/300759.CH): Adjust 2022-24E earnings estimates and cut target price
31
Oct
2022
Mindray (300760.CH): 3Q22 net profit slightly beats, recent policies provide greater certainty in growth
28
Oct
2022
Budweiser Brewing (1876.HK): Premiumization in China continues to be hindered and South Korea's low-base period ended
28
Oct
2022
WuXi AppTec (603259.CH/2359.HK): Core business segments saw meaningful rebound in 3Q; H-share issuance terminated
28
Oct
2022
Topsports (6110.HK): Operational flexibility and efficiency bring forward resilient performance, maintain Buy
10
Oct
2022
Strategic allocation to Hong Kong Equities
22
Sep
2022
Topsports (6110.HK): increases share contribution to Skechers drives revenue growth, and Nike's performance rebound is expected to drive the recovery of valuation
21
Sep
2022
Analyzing exchange rate trends of major economies from a trade balance perspective
21
Sep
2022
SPDBI A-Share Top Picks ROR: Valuation concerns, and financials and healthcare sectors deserve further study
21
Sep
2022
Near-term impact likely limited from the US biomanufacturing executive order; valuation attractive after sell-off
15
Sep
2022
New Energy Vehicle Investment Handbook: new platforms, new products, and new cycle to re-boost growth
15
Sep
2022
US capital flow remains at the first supporting level--Global and US equity flow watch (September 2022)
15
Sep
2022
Significant inflow from energy sector and continuous outflow from financial sector -- China equity flow watch (September 2022)
14
Sep
2022
China e-commerce: structural changes along with decent recovery
14
Sep
2022
Alibaba (9988.HK/BABA.US): adjust FY2023-24E estimates and cut target price
07
Sep
2022
Pharmaron (3759.HK\300759.CH): strong 1H22 results from core business; CDMO leadership reinforced by new manufacturing facility
07
Sep
2022
Technology September Update
02
Sep
2022
Ausnutria (1717.HK): trim 2022-24E estimates and maintain Hold
02
Sep
2022
Yili (600887.CH): Why did Yili lower its 2022 profit margin guidance with beyond expected 1H22 performance?
02
Sep
2022
RemeGen (9995.HK): 1H22 results further validated sales capabilities; overseas development on track
01
Sep
2022
1H22 financial review and outlook of China IMF industry:intensified short- and medium-term competition, and long-term concentration increase
30
Aug
2022
Tsingtao Brewery (168.HK/600600.CH): Better-than-expected performance and better short-term prospects; H-share is more cost-effective than A-shares
26
Aug
2022
Akesobio (9926.HK): Initial sales performance of cadonilimab above expectation; multiple major data readouts in 2023-24
26
Aug
2022
Mengniu Dairy (2319.HK): Positive profit margin guidance expects to turn market sentiment around and boost valuations
26
Aug
2022
Sino Biopharmaceutical (1177.HK):Resilient 1H22 results; in-house R&D and BD will continue to drive innovation
25
Aug
2022
ANTA Sports (2020.HK): retail sales and profit margin improved HOH; low valuation and strong fundamentals provide high cost effectiveness
23
Aug
2022
InnoCare Pharma (9969.HK): Quick ramp-up in orelabrutinib sales after NRDL inclusion; abundant catalysts over the next 12 months
23
Aug
2022
Tongcheng Travel (780.HK):Adjusted 2022-23 estimates and maintain Buy
23
Aug
2022
Mindray (300760.CH): 1H22 results in line with expectation, gross margin impacted by transport expense and FX
22
Aug
2022
Ping An Healthcare(1833.HK):Adjust 2022-24E estimates and maintain Hold
22
Aug
2022
Chongqing Brewery (600132.CH): Wusu expected to resume growth in 2H22 and will drive stock price recovery
22
Aug
2022
WuXi Biologics (2269.HK): Full-year guidance raised; booming CMO business into the next 3 years
22
Aug
2022
Tencent (700.HK): effective cost control, focus on video account monetisation
18
Aug
2022
China Resources Beer (291.HK): Unchanged premiumization trend assist in continuous profit margin expansion
18
Aug
2022
Everest Medicines (1952.HK): New deal achieved with Immunomedics to return Trodelvy rights and replenish cash
16
Aug
2022
Yunkang Group (2325.HK): Adjust 2022-24E estimates and raise the target price
15
Aug
2022
China semiconductor foundry: thoughts amid switching period of a cycle (including SMIC and Huahong 2Q22 earnings results)
15
Aug
2022
Li Ning (2331.HK): Rigorous inventory management is the biggest guarantee for Li Ning’s continuous growth
15
Aug
2022
Robust commercial operations by leading biotech companies in 2Q22, globalization and cross-border collaboration on track
15
Aug
2022
Sector rotation of A-Shares
10
Aug
2022
US equity flows raised to the first support level – Global and US equity flow watch (August 2022)
05
Aug
2022
Equity flow upside down, significant outflow from financial sector -- China equity flow watch (August 2022)
02
Aug
2022
China Dairy Industry: long-term sustainable growth driven by higher health awareness and consumption upgrade
01
Aug
2022
WuXi AppTec(603259.CH、2359.HK): Resilient 2Q22 results amid domestic COVID-19 resurgence, further recovery expected in 2H
01
Aug
2022
Budweiser Brewing (1876.HK):Marginal improving Chinese market and strong performance from Korea and India will escalate BUD APAC’s 3Q22 growth
01
Aug
2022
A two-dimensional analysis of the impact of rate hikes on U.S. consumption
01
Aug
2022
China's innovative oncology drugs: set to ride the secular growth waves in the next decade
27
Jul
2022
Topsport(6110.HK)greatly reduced adidas business proportion to optimize brand structure for long-term healthy development
15
Jul
2022
Price cuts less severe than expected in the seventh round of VBP
13
Jul
2022
Anta (2020.HK)’s beyond-expectation 1H22 retail sales will further assist its profit to beat market expectation
12
Jul
2022
Short-term investment strategy: Anta (2020.HK) share price to rebound
11
Jul
2022
Smartphone optics tracker (July): 2Q22-3Q22 smartphone demand being weak, expectation hitting bottom, waiting for recovery
07
Jul
2022
Significant equity outflows in June——Global and US equity flow watch (July 2022)
07
Jul
2022
Continuing equity inflows in June; significant inflows in consumer sectors -- China equity flow watch (July 2022)
07
Jul
2022
US treasury yields may have peaked amid shift from stagflation to recession; long China growth stocks
04
Jul
2022
Topsports(6110 HK):3 highlights of Topsports’1QFY23 results
04
Jul
2022
Short-term investment strategy: Tongcheng Travel (780.HK) share price to rebound
24
Jun
2022
Sino Biopharmaceutical (1177.HK): VBP impact turning positive, R&D efforts to bear fruits on multiple fronts
22
Jun
2022
Yunkang Group (2325.HK): A powerful enabler for diagnostics operations
17
Jun
2022
1Q22 drug sales at sample hospitals: Sequentially improving, with normalizing impact from the fifth round of VBP
17
Jun
2022
Semiconductor supply chain: China's foundry players fully enjoying the industry upward cycle and the strong demand of domestic substitution
16
Jun
2022
Meituan (3690.HK): Improving visibility in recovery, upgrade to “buy” rating
16
Jun
2022
bilibili (9626.HK、BILI.US): Strong growth momentum in user traffic
14
Jun
2022
Everest Medicines (1952.HK): First TROP2 ADC approved in China, sales guidance above estimate
13
Jun
2022
Volatile rebounded – China equity flow watch (June 2022)
13
Jun
2022
Keep prudent after equity flowing back – Global and US equity flow watch (June 2022)
06
Jun
2022
2022 Outlook: China's economy still likely to outperform, with V-shape recovery in stock market
06
Jun
2022
China economy is still resilient when the world is heading for a perfect storm
06
Jun
2022
Strategy 2H22 outlook: Volatile rebounded
06
Jun
2022
Consumer 2H22 outlook: Gradually switch to more aggressive method in the second half of epidemic
06
Jun
2022
Internet 2H22 outlook: Expect gradual recovery with improving regulatory visibility
06
Jun
2022
Technology 2H22 outlook: 2H22 smartphone expectation hitting bottom, grasping the opportunity of best cost- performance moment
06
Jun
2022
Healthcare 2H22 outlook: Highly attractive valuation after recent volatility, await recovery in 2H22
06
Jun
2022
New energy vehicle 2H22 outlook: pandemic impact bottoming out, and China NEV sales penetration rate continuing to accelerate
01
Jun
2022
Topsports (6110.HK):Strong short-term resilience and adaptability + high long-term growth momentum and investment return
30
May
2022
RemeGen (9995.HK): ASCO 2022 update: Disitamab vedotin demonstrated strong efficacy on urothelial carcinoma
30
May
2022
An estimation of when US stocks will bottom out
30
May
2022
New Energy Vehicle Investment Handbook: Pandemic impact fading away, supply and demand gradually recovering, boosting NEV companies to grow rapidly ( including 1Q22 review/preview of NIO, XPeng, Li Auto Earnings
30
May
2022
Smartphone Supply Chain: 1H22 Weak Shipment and Market Expectation Going through the Trough, looking for defensive names; Top pick Sunny Optical and Luxshare
30
May
2022
Ali Heaith (241.HK): FY22 results in line, with further improvement in direct sales business and fulfillment efficiency
30
May
2022
Li Ning (2331.HK): Seeking the truth within the uncertainties
26
May
2022
Understanding the infrastructure in China
26
May
2022
Kuaishou (1024.HK): Revenue beats with effective cost control
26
May
2022
Daily chart: A high degree of inflation dispersion in Eurozone
25
May
2022
Inflection of Fed appears, and ECB is expected to raise interest rate on July——SPDBI Global Central Bank Monitor (May 2022)
25
May
2022
WuXi Biologics (2269.HK): Business growth above expectation despite domestic COVID-19 resurgence; likely to be taken off UVL by year-end
24
May
2022
Daily Chart: Despite uncertain healthcare funding environment in China, more clinical trials were initiated MoM in April
23
May
2022
Daily chart: Consumer’s increasing concern about sugar intake promotes sales of Better-for-you beverages in China
20
May
2022
Tencent(700.HK):positive policy against economic headwind
20
May
2022
Daily chart: US equity flows fall to the First Support Level
19
May
2022
Sea (SE.US): Shopee is expected to achieve positive adjusted EBITDA in GSEA by the end of 2023, but gaming will be under pressure
19
May
2022
Daily Chart: China's copper stocks dropd to 10-year low
18
May
2022
Daily Chart: The penetration rate of NEV sales in China reached 29.0% in April
17
May
2022
April macro data: When will China's economy rebound from the “late spring coldness”
17
May
2022
Zai Lab (9688.HK): 1Q22 beat; maintain Buy after recent volatility
17
May
2022
Daily Chart: April Camera Module Shipment (Sunny & Q-Tech)
16
May
2022
Daily Chart: China's Internet investment and financing continued to decline in 1Q22
13
May
2022
US equity flows fall to the First Support Level, technical rebound expected while downside risks still remain
13
May
2022
Pou Sheng (3813.HK)’s 1Q22 results reflect optimized operating leverage and improving visibility
13
May
2022
Daily Chart: Global biopharmaceutical investment activities saw a slight MoM slowdown in April 2022
13
May
2022
Investment opportunities under a lingering pandemic and the new normal: focus on post - lock down business recovery and potential long-term benefactors
13
May
2022
Chongqing Brewer (600132.CH)’s sales volume will continue to outperform competitors under pandemic
13
May
2022
April macro data: Increasing food price push inflation up, while the inflation expectation is still manageable
12
May
2022
Daily Chart: Improved cold chain logistics in China accelerates improvements in food safety and consumption upgrades in food industry
11
May
2022
Smartphone optics tracker (May): Weak 2Q22 Demand, CCM Shipment Could Miss Guidance, Yet Pessimism Already Priced In and Remain Bullish on Vehicle Business
11
May
2022
April macro data: China's exports face three-dimensional challenge, while import structure diverges
11
May
2022
Significant equity outflows under multiple market risks -- Global and US equity flow watch (May 2022)
11
May
2022
Daily Chart: The excess return of China growth stocks relative to value stocks has reached historical low
06
May
2022
Framework analysis of the impact of metal price hike on new energy vehicle supply chain.
06
May
2022
Enhanced policy support is coming with equity flow reaching the bottom -- China equity flow watch
06
May
2022
Budweiser Apac (1876.HK): Higher-than-expected 1Q22 result reflects management's flexible resource allocation capabilities
06
May
2022
Yonyou (600588.CH): Cloud transformation continues
06
May
2022
High commodity prices may weaken the impact of rate hikes on EM equities in the short term
05
May
2022
Daily Chart: Delivery of NIO, XPENG, and Li Auto declining
04
May
2022
China CXO Industry: core business posted solid growth momentum in 1Q22; look for longer-term visibility and rerating potential in stock selection
04
May
2022
Pharmaron (3759.HK/300759.CH): 1Q22 revenue beat; impact from domestic COVID-19 resurgence likely moderate and transient
04
May
2022
Daily Chart: 1Q22 India’s Smartphone Shipments Slightly Grew 2% Year Over Year
03
May
2022
Policy Trough Realizing —— Key Takeaways from the April Politburo Meeting
03
May
2022
China beer industry: 1Q22 performance review and future stock selection logic of major players
03
May
2022
April macro data: Demand and Supply Chain Issues Worsen as Economy is Approaching the Bottom
03
May
2022
Tsingtao Brew (168.HK/600600.CH): Pandemic caused A/H valuations to further diverge
03
May
2022
Daily Chart: E-commerce advertising is still a key driver in China’s Internet advertising market
28
Apr
2022
RemeGen (9995.HK): 1Q22 net loss narrower than expected and major risks priced in, maintain Buy
28
Apr
2022
Daily Chart: Sales performances of domestic PD-1/PD-L1 antibodies varied in 2021
27
Apr
2022
Daily Chart: The importance of ready meal will further increase in homes and standardized restaurants
26
Apr
2022
WuXi AppTec (603259.CH/2359.HK): Core segment revenue above expectation, robust growth likely to sustain under the CRDMO model
26
Apr
2022
Daily Chart: The Runoff of Fed's Balance Sheet May Last Till 2025
25
Apr
2022
Daily Chart: Marginal improvements to the bottlenecks in China's supply chain
22
Apr
2022
Li Ning (2331.HK): 1Q22 steady growth under high base provides greater confidence into the market
22
Apr
2022
Daily Chart: YTD price increase of Tesla, NIO, XPENG, Li Auto and BYD in China
21
Apr
2022
March macro data: The pandemic rebound may slow down China's economic recovery
21
Apr
2022
Monetary Policy of the Federal Reserve: Tightening then Easing ——SPDBI Global Central Bank Watch (Apr 2022)
21
Apr
2022
Mindray (300760.CH): 2021&1Q22; post steady growth, driven by rising infrastructure development and procurement
21
Apr
2022
Daily Chart: 2022 CIS revenue share forecast by end market and vendor
20
Apr
2022
Daily Chart: Game licensing resumes in China
19
Apr
2022
ANTA (2020.HK): The epidemic resurgence increased uncertainties of Anta’s operation results
19
Apr
2022
Daily Chart: Global private financing activities recovered MoM in the healthcare sector in March 2022
15
Apr
2022
March macro data: China's imports unexpectedly fell in March, export resilience is still to be tested
15
Apr
2022
Daily Chart: Chinese consumer companies’ marketing strategies will focus more on private traffic
13
Apr
2022
March macro data: Focus on long-term trend of credit expansion and structure improvement
13
Apr
2022
Kingsoft (3888.HK): Release of online gaming license, likely to increase visibility
13
Apr
2022
Multiple data readouts from domestic innovators at AACR and new CDE guidelines guidelines on bispecific antibodies, leading to a clearer path for domestic early-stage R&D efforts
13
Apr
2022
Daily Chart: The equity flow of global market sees further room for downside
12
Apr
2022
Smartphone optics tracker (April): 1Q22 Shipment on track, expecting YoY and QoQ improvement in 2Q22, monitoring demand volatility impacted by the pandemic
12
Apr
2022
March macro data: The narrowing "scissors gap" between PPI and CPI will be tested
12
Apr
2022
Daily Chart: The performance of stock market after the inverted yield curve
11
Apr
2022
Daily Chart: March & 1Q22 Delivery of NIO, XPENG, and Li Auto
08
Apr
2022
Daily Chart: There’s Still Plenty of Room to Grow for Global 5G Mobile Connections (2021 vs 2025E)
07
Apr
2022
Downside remains despite of short-term equity inflow -- Global and US equity flow watch
07
Apr
2022
Bull market is coming as equity flow reaches the bottom -- China equity flow watch
07
Apr
2022
Tongcheng Travel (780.HK): Pandemic is still affecting company in the short run, FY22 performance to fall before rebound
07
Apr
2022
Chongqing Beer (600132.CH) Most defensive in the industry over the short-term. Maintains buy rating, lowers TP
07
Apr
2022
Daily Chart: The scale of Elderly internet users continues to grow; Cost effectiveness becomes ever more important
31
Mar
2022
Daily Chart: Significant drawdown and underwater of US bond market
04
Apr
2022
BYD (1211.HK/002594.CH): 4Q21 Earnings Review: Booster and beneficiary of China NEV penetration "S" curve, expecting sustained high growth in 2022 and 2023.
04
Apr
2022
RemeGen (9995.HK): Rapid ramp-up in product sales and commercialization efforts after NRDL coverage; telitacicept US Phase III trial initiated
04
Apr
2022
Sino Biopharma (1177.HK): FY2021 revenue in line, multiple catalysts to expect within innovative drug pipeline
04
Apr
2022
Daily Chart: HK-listed healthcare companies posted strong earnings growth in 2021, and CXO was the fastest growing subsector
01
Apr
2022
Daily Chart: Development in lower-tier cities and rural markets is the general trend of china’s consumer industry
31
Mar
2022
New Energy Vehicle Investment Handbook: Limited Impact to NEV Demand from Raw Material Price Hike, Slightly Raising NEV Sales Unit Forecast in China after 4Q21 Earnings Review of NIO, XPENG, Li Auto
31
Mar
2022
China's manufacturing and services sectors simultaneously contracted at the bottom of economic cycle
31
Mar
2022
Nayuki (2150.HK): 3 major concerns aggravate uncertainties of Nayuki’s outlook
31
Mar
2022
Short-term investment strategy: Kuaishou (1024.HK) share price to rebound from oversold
30
Mar
2022
Everest Medicines (1952.HK): FY2021 cash burn lighter than expectation, multiple products to enter commercialization in 2022-23
30
Mar
2022
Daily Chart: Analyze the volatile price of nickel, cobalt, and lithium from the trade perspective
29
Mar
2022
PHARMARON (3759.HK/300759.CH): 2022 guidance raised, future expansion to focus on infrastructure and new technologies
29
Mar
2022
Daily Chart: NEV Credits Structure in China in 2021
28
Mar
2022
ZHAOKE OPHTH-B (6622.HK): 2021 cash burn manageable, NDA for CsA ophthalmic gel soon to be filed
28
Mar
2022
Daily Chart: Global 5G Smartphone Penetration Increased Significantly in 4Q21
26
Mar
2022
Daily Chart: The scale of Internet users in China continues to peak, and user dependence continues to rise
25
Mar
2022
WuXi AppTec (603259.CH / 2359.HK): Strong business performance delivered in 2021, capacity expansion and new technology application to speed up in 2022
25
Mar
2022
CR Beer (291.HK): China resources beer plans to raise price in to cover increased cost, and to pursue high-end transformation
25
Mar
2022
Short-term investment strategy: Sunny (2382.HK) share price to rebound from oversold
25
Mar
2022
Optics Industry: Sunny and Q-Tech 2021 earnings review and 2022 outlook: expecting automotive business to grow rapidly, and smartphone business to get improved in 2H22
25
Mar
2022
Daily Chart: Global private financing activities softened YoY in the healthcare sector in 2M22, but still came stronger than 2M20
24
Mar
2022
WUXI BIO (2269.HK): 2H21 results above estimates, global operations and capacity expansion going full steam ahead
24
Mar
2022
Daily Chart: The importance of inventory optimization to the quality improvement of retail operations
23
Mar
2022
Short-term Investment Strategy Termination:Li Ning (2331.HK)
23
Mar
2022
ANTA Sports (2020.HK): Anta continues to focus on long-term, high-quality, sustainable revenue and profit growth
23
Mar
2022
Daily Chart: The money outflow of Hong Kong stocks has reached a significant level
23
Mar
2022
China's Internet Industry: Can a ray of light in the darkness lead the Internet out of the haze? ——Review the "3.16 meeting" and the future market outlook
21
Mar
2022
Li Ning (2331.HK) : Li Ning continues to improve internal drivers with overall market sentiment bottoms out
21
Mar
2022
Daily chart: Two dimensions of China's stable growth policy
19
Mar
2022
How much money is flowing back to Hong Kong stocks? And how to allocate among sectors?
19
Mar
2022
Li Ning (2331.HK):2H21 financial performance interpretation and its 2022 outlook
18
Mar
2022
Daily Chart: The penetration rate of NEV sales in China reached 21.6% in February
17
Mar
2022
How to interpret the FOMC meeting on Mar 2022?——Inflation driven rate hikes, and balance sheet reduction approaching
17
Mar
2022
PA GoodDoctor (1833.HK): FY2021 results in line, awaiting visibility amid strategy shifts
17
Mar
2022
Short-term investment strategy: Luxshare (002475.CH) share price to rebound from oversold
17
Mar
2022
Luxshare (002475.CH): Consumer electronics business expanding despite of declining smartphone demand and automotive electronics business supporting long - term growth.
17
Mar
2022
Short-term Investment Strategy Termination:Li Auto-W (2015.HK)
17
Mar
2022
Short-term Investment Strategy Termination: XPENG-W (9868.HK)
17
Mar
2022
Daily charts:Tech companies’ retreat affects millions of Russians
16
Mar
2022
China drug sales quarterly tracker (2022 Vol.01): 4Q21 drug sales at sample hospitals in China: The fifth round of VBP began to take its toll
16
Mar
2022
4Q21 drug sales at sample hospitals in China: The fifth round of VBP began to take its toll
16
Mar
2022
Daily chart: China's cloud game revenue increased by 93% in 2021
16
Mar
2022
POU SHENG INT'L(3813.HK): 4Q21 results highlighting its operational weakness compared with Topsports, downgrade TP
16
Mar
2022
Short-term investment strategy: Li Auto (2015.HK) share price to rebound from oversold
16
Mar
2022
Short-term investment strategy: XPENG (9868.HK) share price to rebound from oversold
15
Mar
2022
February macro data: Focus on the long-term trend of the credit expansion and inflation
15
Mar
2022
Daily Chart: China’s public health insurance fund gained surplus in 2021; future directions of reform reiterated at the Two Sessions
14
Mar
2022
Smartphone Optics Tracker (March): CCM fundamental under pressure, valuation having fallen sharply, factoring in pessimistic expectation, and expecting 2Q22 fundamentals to be improved.
14
Mar
2022
Daily chart: Large geographical gap in dairy product demand in China
11
Mar
2022
Daily chart: Our leading indicator shows that China's economy will soon bottom out
10
Mar
2022
Hang Seng Index touches its 250-month moving average —add positions of Hong Kong stocks
10
Mar
2022
Short-term investment strategy: Li Ning (2331.HK)’s stock price expect to rebound in the next month
10
Mar
2022
Daily chart: A two-dimensional view of the RMB exchange rate, after the Russia-Ukraine conflict
09
Mar
2022
February macro data: Structural resilience of exports will face challenges, growth rate has seen a slowdown
09
Mar
2022
China beer industry: the analysis on the impact of raw material price hike led by Russia-Ukraine war
09
Mar
2022
Daily Chart: Quick View - February Delivery of NIO, XPENG, and Li Auto
08
Mar
2022
Bilibili (9626.HK/BILI.US): Breakeven target in 2024
08
Mar
2022
Daily Chart: The Shipment of Apple’s iPhone increased significantly in 2021
07
Mar
2022
Actively pursue growth and stabilization ——Government Work Report 2022
07
Mar
2022
Daily Chart: Time spent on mobile game by category in China
04
Mar
2022
Zai Lab(9688.HK):FY2021 revenue in line, significant progress made in R&D, BD and commercialization
04
Mar
2022
Sea (SE.US):weak game guidance
04
Mar
2022
Daily Chart: The CDE's regulatory review process has been accelerating, and the new guidelines for breakthrough therapies may further help
02
Mar
2022
February macro data:Improved demand drives manufacturing PMI up slightly, non-manufacturing expansion accelerates as expected
02
Mar
2022
Daily Chart: Heineken joins hands with CRB will change the current high-end beer market’s competitive pattern in China
01
Mar
2022
Li Auto (LI.US/2015.HK): Li Auto (LI.US/2015.HK): Raising Price Target on Strong 4Q21 Earnings Performance and Rapid Expansion in 2022 and 2023
01
Mar
2022
Short-term investment strategy: Expecting multiple catalysts to drive near-term share performance for Everest Medicines (1952.HK)
01
Mar
2022
Alibaba (9988.HK/BABA.US): CMR declines slightly; solid growth in taobao deal
01
Mar
2022
Daily chart: Our proprietary indicator is giving a buy signal of Chinese stocks.
28
Feb
2022
Daily Chart: China's local governments set conservative growth targets for 2022, Hainan's target ranked first
25
Feb
2022
Chinese Stocks: Add positions
25
Feb
2022
How does the Russia-Ukraine conflict affect the current global economic recovery?
25
Feb
2022
Budweiser APAC (1876.HK): Robust 4Q21 results reflecting sustainable premiumization capability, raise TP to HK$31.0
25
Feb
2022
Daily Chart: 2021 Retails Sales Volumes Ranking by NEV Models
24
Feb
2022
Meituan (3690.HK): still cautious on policy headwind
24
Feb
2022
Daily Chart: 2021 Worldwide TOP 10 Semiconductor Consumers
23
Feb
2022
Mindray (300760.CH): Chinese medical device leader, best yet to come
23
Feb
2022
Daily Chart: China's gaming gross sales revenue grew 6.4% in 2021
22
Feb
2022
Daily Chart: The expected IRR for global biopharmaceutical innovation rebounded to 7.0% in 2021, mainly thanks to COVID-19 projects
21
Feb
2022
RemeGen(9995.HK): Full-year 2021 revenue in-line, with profit turnaround achieved; 2022 likely a fruitful year in R&D and commercialization
21
Feb
2022
Daily Chart: China dairy industry(1): China’s per capita dairy sales ranks at bottom globally
18
Feb
2022
TopSports (6110.HK): Retail sales rebounded earlier than expected, market sentiment gradually recovered
18
Feb
2022
Sea(SE.US):Free Fire banned in India, globalization still on track
18
Feb
2022
Stronger tightening monetary policy: tightening pressure will reach the highest in 1H22 ——SPDBI Global Central Bank Watch
18
Feb
2022
Daily Chart: Supply bottleneck is the main contribution to US high inflation
17
Feb
2022
China's January Macro Data: Inflation stabilized prior to Lunar New Year of 2022
17
Feb
2022
Daily Chart: Weak expectation on income and employment , rising propensity to saving than consumption
16
Feb
2022
WuXi AppTec (603259.CH/2359.HK): 2021 results above preliminary range, management expecting >60% revenue growth in 2022
16
Feb
2022
Daily Chart: January Delivery of NIO, XPENG, and Li Auto
15
Feb
2022
Daily Chart: January Camera Module Shipment (Sunny & Q-Tech)
15
Feb
2022
Smartphone Optics Tracker (February): Smartphone CCM entering light season, and facing YoY pressure; vehicle lenses resuming growth
14
Feb
2022
Daily Chart: China's passenger trips increase substantially during the Spring Festival in 2022
14
Feb
2022
China's January Macro Data: China's credit growth picks up, leading to stronger-than-expected aggregate social financing
11
Feb
2022
Innovent/Lilly's US BLA for sintilimab hit a wall at the FDA. What's next?
11
Feb
2022
Daily Charts:Preliminary FY2021 results of CXO companies showed strong revenue and earnings growth
10
Feb
2022
Daily Charts:Chinese brands are seizing market share in many consumer subcategories
09
Feb
2022
Daily Charts:Super backwardation of WTI crude oil futures
08
Feb
2022
Daily Charts:A significant epidemic rebound in 2022 drove up China export containerized freight index
08
Feb
2022
China's January Macro Data: Weak demand and temporary factors affected the manufacturing and non-manufacturing expansion respectively
08
Feb
2022
Chongqing Brewery (600132.CH): 2021 NP beat our expectation, 2022 Wusu sales growth likely to maintain strong
08
Feb
2022
WuXi Biologics (2269.HK): FY2021 preliminary results above expectation, ramp-up of CMO segment to drive strong future growth
08
Feb
2022
WuXi Biologics (2269.HK): Inclusion in the US Commerce Department's Unverified List likely to have limited impact
07
Feb
2022
Daily Charts:China 2021 Retail Sales Volume Ranking by NEV Manufactures
04
Feb
2022
Daily Charts:4Q21 Global Smartphone Shipment Share by Brand
31
Jan
2022
Generation Z become main contributor of China eCommerce new users
28
Jan
2022
Daily Chart: Sino Biopharma's Taibowei has become the sixth adalimumab approved in China
28
Jan
2022
Ping An Healthcare and Technology (1833.HK): Near-term revenue pressure amid strategy shifts; move to Hold
27
Jan
2022
China beer industry: Cheers! Duel in the field of high end market by embracing premiumization!
27
Jan
2022
Daily Chart: Analysis of China consumer sector stock price performance in early 2022
27
Jan
2022
TOT Biopharm(1875.HK): Discontinuation of coverage (2022-01-26)
26
Jan
2022
Daily Chart: Bearish sentiment of US stock market is shooting up
25
Jan
2022
Daily Chart: Improvement of the financing side will be the key to China's real estate developers
25
Jan
2022
Pharmaron (3759.HK/300759.CH): Full-year 2021 results largely in line, 2022 a critical year for capacity expansion
24
Jan
2022
Daily Chart: The penetration rate of NEV sales in China reached 20.6% in December
21
Jan
2022
Daily Chart: Global smartphone shipment growth from high to low in 2021
21
Jan
2022
Anta (2020.HK): profit alert largely in line with our expectation, with more specific 2022 guidance from management
21
Jan
2022
China's December Macro Data: How is China’s economic recovery in the last quarter of 2021
20
Jan
2022
Daily Chart: The future growth of short video will be driven by advertising and e-commerce
20
Jan
2022
Wuxi AppTec (603259.CH/2359.HK): Preannounced 2021 full-year results beat; 2022 revenue growth set to further accelerate
19
Jan
2022
Daily Chart: 86.25% of China’s population has been fully vaccinated against COVID-19, according to the NHC
19
Jan
2022
Wingtech (600745.CH): 2022 SPDBI Corporate Day takeaways
19
Jan
2022
Sunny Optical (2382.HK): 2022 SPDBI Corporate Day takeaways
19
Jan
2022
BYD Electronic (285.HK): 2022 SPDBI Corporate Day takeaways
19
Jan
2022
Xiaomi (1810.HK): 2022 SPDBI Corporate Day takeaways
19
Jan
2022
NewBornTown (9911.HK): 2022 SPDBI Corporate Day takeaways
19
Jan
2022
Tongcheng Travel (780.HK): 2022 SPDBI Corporate Day takeaways
19
Jan
2022
RemeGen (9995.HK): 2022 SPDBI Corporate Day takeaways
19
Jan
2022
WuXi Biologics (2269.HK): 2022 SPDBI Corporate Day takeaways
19
Jan
2022
Mengniu Dairy (2319.HK): 2022 SPDBI Corporate Day takeaways
19
Jan
2022
Topsports (6110.HK): 2022 SPDBI Corporate Day takeaways
19
Jan
2022
Li Ning (2331.HK): 2022 SPDBI Corporate Day takeaways
19
Jan
2022
ANTA Sports (2020.HK) 2022 SPDBI Corporate Day takeaways
19
Jan
2022
Wingtech (600745.CH): Semiconductors, ODM, and optical business on growth
19
Jan
2022
Inflation pressure and tightening of liquidity are still lasting ——SPDBI Global Central Bank Watch
18
Jan
2022
Daily Chart: Demonstrating the importance of earnings quality with Li Ning's historical financials
17
Jan
2022
Daily Chart: Marginal ease of global supply chain pressures
14
Jan
2022
What the Beveridge Curve told us about the current U.S. job market?
13
Jan
2022
BYD NEV Sales in 2021
12
Jan
2022
Daily Chart: September & 2021 Camera Module Shipment (Sunny & Q-Tech)
12
Jan
2022
Pharmaron (3759.HK/300759.CH): Acquisition of a UK-based API manufacturing facility to enhance overseas CDMO capabilities; impact from recent COVID-19 resurgence likely manageable
11
Jan
2022
Daily Chart: Mobile game advertising was the largest segment in China's mobile ad market in 2021
10
Jan
2022
Daily Chart: Private financing activities for Chinese healthcare companies picked up in 2021
07
Jan
2022
Daily Chart:The retail consumer goods performance largely depends on the recovery of consumer sentiment
06
Jan
2022
Daily Chart:The word frequency of “inflation” in financial reports of S&P 500 has reached record high
05
Jan
2022
Daily Chart:The impact of Indonesia's coal export ban on China
05
Jan
2022
Short-term Investment Strategy Termination: RemeGen (9995.HK)
05
Jan
2022
RemeGen (9955.HK): Management refuted allegations on internal control loopholes and provided positive clinical updates; reiterate Buy
05
Jan
2022
China's December Macro Data: the overall economy continued to expand, while small enterprises profit squeeze and the epidemic rebound needed to be considered
04
Jan
2022
Daily Chart: December & 2021 Delivery of NIO, XPENG, and Li Auto
03
Jan
2022
Short-term investment strategy: RemeGen (9955.HK) to rebound from oversold
03
Jan
2022
Daily Chart: 3Q21 global foldable smartphone shipments grew 480% year over year
03
Jan
2022
The discrepancy between buy side and sell side in sector allocation
03
Jan
2022
The elasticity of each sector under decreasing global fund flows
03
Jan
2022
Prediction of a downward cycle in 1H22 by US treasury yield
31
Dec
2021
Daily Chart:US bank deposits surged above the pre-pandemic trend due to the fiscal support
24
May
2021
Alibaba (9988.HK): 30%+ YoY FY22 topline growth target; margin pressure from investments
31
Dec
2021
Sino Biopharmaceutical (1177.HK):Solid fundamental and a good entry point after recent corrections; initiate at Buy
18
May
2021
China's April Macro Data: Investment and exports led to steady industrial production growth, while consumption recovery not quite on track
30
Dec
2021
Alternative views of US inflation
18
May
2021
Everest Medicine (1952.HK): Trodelvy BLA accepted by NMPA, far earlier than expected
30
Dec
2021
Behind the underperforming of internet sector in 2021
18
May
2021
A revelation for sector rotation strategies: Will the sector rotation continue?
30
Dec
2021
China's November Macro Data: Cost pressures temporarily pull down industrial profits, while the inventory stock continue to increase
18
May
2021
China Youzan (8083.HK):Revenue growth slows down, lower TP to HK$2.1
30
Dec
2021
Daily Chart: Drug sales and pricing at PDB sample hospital in 3Q21 (by major therapeutic area)
18
May
2021
China's April Macro Data: liquidity turning point reconfirmed, “scissors gap” between CPI and PPI is worrisome
29
Dec
2021
Daily Chart:The correlation between China birth rate and IMF sales volume
17
May
2021
Perspectives of global QE taper—SPDBI Global Central Banks Watch
28
Dec
2021
Daily Chart:The fund flow of global equity market is over the sum of past 15 years
14
May
2021
Short-term investment strategy: Everest Medicines (1952.HK) has upside potential in the short-term
14
May
2021
TOT Biopharm (1875.HK): CDMO progress better than expected, bevacizumab biosimilars competition becomes fierce
24
Dec
2021
Short-term investment strategy: RemeGen (9955.HK) to rebound from oversold
12
May
2021
Smartphone Optics Tracker: Shipment Momentum of Q-Tech’s CCM and Sunny’s Handset Lens Going Weak in April, Smartphone Demand Weakening or Semiconductor Capacity Limitation?
24
Dec
2021
Credit impulse has bottomed out: we are not far away from the market bottom
11
May
2021
China's April Macro Data: Rapid trade growth, and container shipping boom driven by both demand and supply sides
24
Dec
2021
Convexity of gold price and increasing real yield make gold under pressure
04
May
2021
China's April Macro Data: Economic expansion slowed down but with a more balanced structure
24
Dec
2021
Daily Chart:Tencent’s investment portfolio
04
May
2021
Wuxi AppTec (603259.CH/2359.HK): Growth momentum continues, CDMO segment delivered robust growth
24
Dec
2021
Short-term Investment Strategy Termination: Topsports (6110.HK)
04
May
2021
Pharmaron (300759.CH/3759.HK) Earnings doubled in 1Q21, aggressive expansion to provide end to end service
24
Dec
2021
Market Cap Strategy of China A Shares under Different Volatility Environments
28
Apr
2021
China's March Macro Data: A steady growth of industrial profit with a rising inventory as expected
23
Dec
2021
Short-term Investment Strategy Termination: Luxshare (002475.CH)
28
Apr
2021
Meituan (3690.HK): Maintain “Neutral”; Caution on near-term headwind
23
Dec
2021
Daily Chart: The penetration rate of NEV sales in China reached 17.8% in November
26
Apr
2021
Will Semiconductor (603501.CH): 2020 & 1Q21 Earnings: CCM Demand Strong, Omnivision Gaining Share within CIS of High-end Smartphone and Automotive
23
Dec
2021
Alibaba Health(241.HK): Potential regulatory changes still pose near-term risks but long-term growth prospects remain intact
22
Apr
2021
Hengrui Medicine (600276.SS) 2020 and 1Q21 results: Earnings in line, new blockbuster drugs growth momentum continued (meeting minutes attached)
23
Dec
2021
Top Esports(6110.HK): Short-term challenges from supply chain continue, but the long-term fundamental advantages remain unchanged
21
Apr
2021
New Oriental Education (9901.HK) 3QFY21 Earnings: Earnings beat with strong guidance
23
Dec
2021
China’s 2022 Economic Outlook after the Central Economic Work Conference
20
Apr
2021
China's March Macro Data: Four highlights about China’s economic recovery in 1Q21
22
Dec
2021
Short-term investment strategy:expect supply chain issue continues to negatively impact Topsports’ (6110.HK) 4QFY22 retail performance
16
Apr
2021
Zai Lab (9688.HK): TTFields phase III trial in NSCLC may be accelerated, Zejula reimbursement negotiated price disclosed
22
Dec
2021
Daily Chart: Camera Module November Shipment Comparison: Sunny vs Q-Tech
16
Apr
2021
Huawei:2020 Annual Report and 2021 HAS Read: Moving forward through times of uncertainty
21
Dec
2021
Daily Chart:China’s gaming industry revenue from the overseas market is growing rapidly
14
Apr
2021
Gold investment analysis framework: Bottom fishing now?
21
Dec
2021
Accelerated Taper and Further Tightening of Liquidity ——SPDBI Global Central Bank Watch
14
Apr
2021
SPDBI Global Central Banks Watch: How will central banks respond to the upward shift of the global nominal interest rate
20
Dec
2021
Short-term investment strategy: Lens (300433.CH) share price to rise
13
Apr
2021
Alibaba (8083.HK): Regulation risk mitigated, buy on dip.
20
Dec
2021
Short-term investment strategy: Luxshare (002475.CH) share price to rise
13
Apr
2021
Smartphone Optics Tracker: Sunny and Q-Tech Early Pull-in Effect Fading, Largan April and May Revenue Guidance Weak
20
Dec
2021
How to interpret the FOMC meeting on Dec 2021?——Beware of potential drawdown of risk assets in 1H22
09
Apr
2021
Different cycle this time?——market cycle analysis framework series (2)
20
Dec
2021
CXO: Growth prospect remain positive; good entry point after recent volatility
08
Apr
2021
China's March Macro Data: China's full economic recovery starts
20
Dec
2021
Sea(SE.US): The rising star from Southeast Asia
08
Apr
2021
Short-term Investment Strategy Termination: China Youzan (8083.HK)
17
Dec
2021
Daily Chart: 3Q21 drug sales at PDB sample hospitals dropped 1.7% YoY
01
Apr
2021
Wuxi AppTec (2359.HK) 2020 annual results: Stable revenue growth, gains from investment contributed earnings
17
Dec
2021
Everest Medicines (1952.HK):Re-appreciation of the in-licensing model expected, maintain Buy
31
Mar
2021
BYD Electronic (285.HK) 4Q20 Earnings: Core Global Client Growing Rapidly, Driving Earnings Growth
17
Dec
2021
China's November Macro Data:Industrial production continued to recover, investment decline narrowed, while consumption is still weak
31
Mar
2021
Xiaomi (1810.HK) :Xiaomi Entering EV, Alive!
17
Dec
2021
How to interpret the crash of healthcare sector from short sell ratio?
30
Mar
2021
China's February Macro Data: industrial profit is off to a good start with inventory growth
17
Dec
2021
Short-term investment strategy:Li Ning’s sell through of next 3 months likely to beat market expectation
30
Mar
2021
Pharmaron (3759.HK) 2020 annual results: Gross margin improved, M&A will be another leg of growth
17
Dec
2021
Lining(2331.HK): 2022 revenue growth likely to beat market expectation underpinned by brand equity elevation and store expansion
30
Mar
2021
RemeGen (2269.HK) 2020 annual results: ADC drug expected to launch this year, raise target price
17
Dec
2021
iPhone Supply Chain: Chinese Manufacturers to Build Integrated Assembly Platforms and to Enjoy Long-term Growth
30
Mar
2021
Meituan (3690.HK):low visibility in online grocery initiatives, downgrade to “Hold”
16
Dec
2021
Ming Yuan Cloud(909.HK): Cut TP on uncertainties in real estate industry
30
Mar
2021
China Youzan (8083.HK): lower-than-expected revenue along with improving GPM
16
Dec
2021
Weimob(2013.HK): Headwind in advertising
29
Mar
2021
Wuxi Biologics (2269.HK) 2020 annual results: Better than expected earnings, capacity expansion unveil growth potential
16
Dec
2021
Daily Chart:The concentration analysis of China beer market
29
Mar
2021
Q Technology (1478.HK) 2H20 Earnings: CCM on the Rise
15
Dec
2021
Daily Chart:Diminishing marginal impact of the pandemic on transportation
25
Mar
2021
Tencent (700.HK): Inline 4Q result, decent growth across all segments
14
Dec
2021
China's November Macro Data: Scissors gap between PPI and CPI will continue to narrow, the bottoming rebound of social financing growth is expected
25
Mar
2021
Tongcheng-Elong (780.HK) 2021 focus: paying user+ accommodation business
02
Nov
2021
Nayuki (2150.HK): The profit warning has validated our concern and is likely to depress market confidence
14
Dec
2021
Daily Chart: Both the primary and secondary housing markets have shown a cooling trend in China
26
Nov
2020
Bevacizumab biosimilars on ESMO and competitive landscape in China
25
Mar
2021
TOT Biopharm (1875.HK) 2020 annual results: Several drugs expected to launch, TAA013 phase III trial on track
02
Nov
2021
Short-term investment strategy: Yonyou (1952.HK) to rebound from oversold
26
Nov
2020
Tongcheng-Elong 3Q20 Earnings: inline 3Q result; soft 4Q guidance
02
Nov
2021
China's October Macro Data: The manufacturing and non-manufacturing PMI fell due to the weak production and rebound epidemic
13
Dec
2021
Daily Chart: November Delivery of NIO, XPENG, and Li Auto
26
Nov
2020
Ali Health 1HFY21 Earnings: Turnaround first time with strong growth of online pharmaceutical direct sales and platform business
25
Mar
2021
Everest Medicine (1952.HK) 2020 annual results: R&D expense increased, key drugs progressed well
02
Nov
2021
Daily Chart: Tesla has become the first car manufacturer to hit trillion-dollar market cap
25
Nov
2020
Xiaomi 3Q20 Earnings: Clear Visibility into Smartphone Growth
01
Nov
2021
Daily Chart: Comparison between emerging and developed smartphone markets by price segment
14
Dec
2021
Zai Lab (9688.HK): BD and commercialization progressing well; upgrade to Buy
19
Nov
2020
China's October Macro Data: Different V-shaped recovery among industrial production, investment, and consumption
25
Mar
2021
Xiaomi (1810.HK) 4Q20 Earnings: GM Improving, and Opex/sales Increasing
01
Nov
2021
TopSports (6110.HK): Better-than-expected NP in 1HFY22, sequential recovery in 2HFY22, and strong fundamental in the long term
17
Nov
2020
Alibaba: Review on 2020 “Double 11”
01
Nov
2021
Global Commodities: Change of CAPEX Structure——Supply-side Multidimensional Series Report (2)
10
Dec
2021
Daily Chart: 3Q21 Global smartphone Shipments Breakdown by Regions
13
Nov
2020
Tencent 3Q20 Earnings: A solid quarter driven by mobile games
24
Mar
2021
Short-term Investment Strategy Termination: Pharmaron (3759.HK)
29
Oct
2021
Daily Chart: China’s vertical SaaS is experiencing rapid growth
12
Nov
2020
China's October Macro Data: Macro leverage will drive economic recovery
28
Oct
2021
Pharmaron(3759.HK、300759.CH):3Q21 results: Results in-line with expectation, lab service reports robust growth
09
Dec
2021
Daily Chart: China’s Internet investment and financing increased in the number of transactions and decreased in the amount of funding in 3Q21
12
Nov
2020
Uni-President (220 HK): 3Q20 Net Profit Beat on Double-digit Decline in Expense
24
Mar
2021
Sino Biopharm (1177.HK) 2020 annual results: Earnings beat the market, multiple blockbusters expected to launch in 2021
28
Oct
2021
Li Ning(2331.HK):The top-up placement to bode well for long-term business expansion, despite short-term stock price volatility
10
Nov
2020
China's October Macro Data: This is not the beginning of deflation
28
Oct
2021
Daily Chart: the global surgical robot market booms
09
Dec
2021
China's November Macro Data: China’s exports stayed resilient, while the trade surplus will gradually narrow
10
Nov
2020
Smartphone Optics Tracker: October shipment dragged by Huawei, supply chain boosted as election results come to an end
19
Mar
2021
Sunny Optical (2382.HK): 2020 Earnings Beating Expectation, 2021 Guidance Remaining Strong
27
Oct
2021
Daily Chart: The beer ASP in China is significantly below the international level
09
Nov
2020
Quick Comment: Tingyi (322 HK) To Change CEO
26
Oct
2021
Li Ning(2331.HK):Soar against headwind – 3Q21 retail sell-through significantly ahead of competitors, demonstrating strong brand equity
09
Nov
2020
China’s October Macro Data: RMB strengthens as trade surplus widens
18
Mar
2021
An optimistic but cautious asymmetrical adjustment by the Fed
26
Oct
2021
Daily Chart: Observing the upgrading of China's manufacturing industry from the structure of employees
06
Nov
2020
SPDBI Global Central Banks Watch:Pandemic Resurgence: Easing and diverging monetary policies as well as a potentially strong U.S dollar ahead
25
Oct
2021
Daily Chart: China property market and lukewarm land sales
03
Nov
2020
Pharmaron 3Q20 results: Margins improvement continue
16
Mar
2021
China's February Macro Data:Growing industrial production, steady investments, and delayed consumption rebound
22
Oct
2021
Daily Chart: The penetration rate of NEV sales in China fell slightly in September compared with August
03
Nov
2020
Wuxi AppTec 3Q20 Results: Large backlog value indicates high growth visibility
22
Oct
2021
Further Marginal Tightening of Overseas Market Liquidity——SPDBI Global Central Bank Watch
08
Dec
2021
Daily Chart: China bevacicumab biosimilar market on the rise
02
Nov
2020
China's October Macro Data: The growth baton passes from manufacturing sectors to non-manufacturing sectors
15
Mar
2021
Kuaishou (1024.HK): the lens to a wider world
21
Oct
2021
Daily Chart: Apple strengthens its iPhone portfolio again
31
Oct
2020
14th Five Year Plan: From Quantitative to Qualitative: The Road towards an Innovative and High Income Economy
20
Oct
2021
Daily Chart: SEA Internet economy still has great growth potential
07
Dec
2021
Daily Chart: The contribution of e-commerce channel to China’s consumer retail industry may continue to increase
30
Oct
2020
'New' economy-dominated MSCI China , a new champion
12
Mar
2021
China's February Macro Data:Aggregate financing speeds up while the trend is downward; Inflation has crossed the peak of base effect
19
Oct
2021
Anta (2020.HK): 3Q21 retail performance within expectation; new norm of Fila set to release long-term value
30
Oct
2020
BYDE (285.HK) 3Q20 Earning: Riding on Core Global Client, Rapid Growth for the Next Three Years Waiting Ahead
19
Oct
2021
Global Commodities: Revenge from CAPEX—Supply-side Multidimensional Series Report (1)
07
Dec
2021
2021 NRDL negotiation results: numerous homegrown innovation drugs successfully included
28
Oct
2020
Transsion: 3Q20 Earnings Beat Expectation, Net Profit YoY Accelerating
12
Mar
2021
SPDBI Global Central Banks Watch:Treasury yields may still rise, while in a gentle slope
19
Oct
2021
Daily Chart: China's pharmaceutical market size continues to grow
27
Oct
2020
China's September Macro Data: September Industrial Profit Growth Normalized as Pandemic Effect Faded
18
Oct
2021
Daily Chart: Impact of recent raw milk prices in china on profitability of china's dairy industry
27
Oct
2020
BYDE (285.HK): Rapid Growth from Core Global Client
11
Mar
2021
Smartphone Optics Tracker: Feb high growth off last year’s low base
15
Oct
2021
Daily Chart: the preference for primary market in China for medical, manufacturing, consumption and artificial intelligence industry has increased.
21
Oct
2020
Why positions of internet & tech stocks changed dramatically?
15
Oct
2021
China's September Macro Data: Structural competitiveness drives exports to keep rising
20
Oct
2020
Identify Cosmetics Consumption Trends from Li Jiaqi 11.11 List
10
Mar
2021
China's February Macro Data:Exports remained resilient; imports held steady
13
Oct
2021
手机和车载光学行业月度追踪(2021年10月刊)
19
Oct
2020
China's September Macro Data: Asymmetric V-shaped recovery
13
Oct
2021
每日一图:疫情期间,全球房地产价格增速分化
06
Dec
2021
New Energy Vehicle 2022 Outlook: Global NEV Sales on Rapid Growth, Chinese Automotive Makers Boosting China NEV Sales Penetration Increase to Accelerate
16
Oct
2020
Micro to macro strategy: Great changes of US inflation not seen in 25 years?
09
Mar
2021
NEV: From over-heat to rational, to buy or not to buy?
12
Oct
2021
每日一图:9月蔚来、小鹏交付量均首次破万
16
Oct
2020
China's September Macro Data: Downward pressure on inflation
11
Oct
2021
每日一图:最新发布的iOS15仍可支持iPhone6s 6sPlus及之后的机型
06
Dec
2021
Healthcare 2022 Outlook:Focusing on innovators with rerating potential and high visibility
15
Oct
2020
Xiaomi Smartphone Market Size Revisit: Huawei Honor vs Xiaomi
05
Mar
2021
A look at Hang Seng Index's biggest overhaul
08
Oct
2021
每日一图:短视频时长占比不断提升,成为最大品类
15
Oct
2020
Ten key questions about Tencent
08
Oct
2021
哔哩哔哩(9626.HK、BILI.US):感性刷弹幕,理性看恰饭 ——从内容和变现的“破”与“不破”看投资核心逻辑
06
Dec
2021
Technology 2022 Outlook: Smartphone demand on track of recovery, expecting sector fundamental trend of from down to up in 2022, opposite of that in 2021
15
Oct
2020
China's September Macro Data: Neutral monetary policy and rapid growth in total social financing
05
Mar
2021
Zai Lab (9688.HK) 2020 Annual Results: Gross margin decreased, while two drugs are expected to be approved in 2021
07
Oct
2021
每日一图:稳健增长的中国大健康市场
14
Oct
2020
Apple 2020 Launch Event: Is iPhone 12 Series Pricing Juicy or Not?
06
Oct
2021
每日一图:中国运动服饰行业双低预示未来较大增长空间
06
Dec
2021
Internet 2022 Outlook:Valuation attractive; expect rebound in 2022E
13
Oct
2020
China's September Macro Data: Balanced recovery in exports and imports
02
Mar
2021
Short-term investment strategy: China Youzan (8083.HK) to rebound from oversold
05
Oct
2021
9月中国宏观数据点评——制造业短期继续分化,疫情稳控助力服务业反弹
13
Oct
2020
Internet Healthcare: This is the Time
05
Oct
2021
每日一图:全球雇佣前景指数反映美国就业市场状况良好
06
Dec
2021
Consumer 2022 outlook :Every cloud has a silver lining
13
Oct
2020
Smartphone Optics Tracker: High-end Smartphone Demand Continues to be Weak and Significant Discrepancy Exists Among Companies
02
Mar
2021
China Youzan (8083.HK): Main Board Listing to unlock value
04
Oct
2021
每日一图:全球通胀走高,但程度仍不及2008年
12
Oct
2020
SPDBI Global Central Banks Watch:Global monetary policy further easing, a farewell to stronger EUR
28
Sep
2021
Li Ning (2331.HK): Short-term slowdown of retail sell-through growth and stock correction to reshape market expectation, highlighting the long-term investment thesis
06
Dec
2021
2022 Outlook: China's economy likely to outperform, with V-shape recovery in stock market
09
Oct
2020
Largan (3008.TW) 3Q20 Earnings Call Takeaway: 4Q20, Not a Strong Busy Season
02
Mar
2021
China's February Macro Data: PMI Moderately Declined Amid Growth Driver Transition
24
Sep
2021
Everest Medicine (1952.HK): License-in BTK inhibitors; collaborate with partners to extend R&D frontier
30
Sep
2020
China's September Macro Data: A simultaneous recovery of manufacturing and non-manufacturing sectors
23
Sep
2021
Thoughts on Helens and China pub industry: great room for growth riding on premiumization in low-tier cities
28
Sep
2020
China's August Macro Data: A continuous recovery of industrial profits and revenue
25
Feb
2021
Strategist ’s commentary: Hong Kong's first trading tax hike and its impacts on the stock market
21
Sep
2021
Global equity flow is showing sign of peaking, and investors are advised to remain cautious.
28
Sep
2020
Nongfu Spring (9633 HK): Maiden 1H20 Results Muted; Capturing Category Evolution is the key
16
Sep
2021
Apple September 2021 Launch Event: iPhone 13 Series Upgrade Direction
06
Dec
2021
2022 Strategy Outlook: From down to up, be cautious in the 1H22
17
Sep
2020
Xiaomi Initiation Roadshow Feedback: Revisit Huawei Market Space and Xiaomi Valuation
25
Feb
2021
Short-term investment strategy: Pharmaron (3759.HK) to rebound from oversold
16
Sep
2021
US and Eurozone about to taper QE, first rate hike in South Korea—SPDBI Global Central Banks Watch
17
Sep
2020
Bear Market or Correction? - Market Cycle Analysis Framework Reports Series (1)
15
Sep
2021
Everest Medicine (1952.HK): License in mRNA COVID-19 vaccine, potential use as booster shots
06
Dec
2021
2022 Macro Outlook: China’s stable growth in the context of global economic recovery
16
Sep
2020
Apple September 2020 Launch Event: Paving a Road of Cost Performance for iPad and Apple Watch
25
Feb
2021
Pharmaron (3759.HK) Earnings Preview: Growth stage, with volatile investment income
14
Sep
2021
Smartphone Optics Tracker: The weak demand of smartphone CCM in 3Q21 within expectations, and looking for the demand YoY improvement in 4Q21
15
Sep
2020
China's August Macro Data: The overall recovery in industry, investment, and consumption
07
Sep
2021
New Energy Vehicle Investment Handbook: Significantly Raising NEV Sales and Penetration Forecasts in China after 2Q21 Earnings Review
14
Sep
2020
Smartphone Optics Tracker: CCM Overseas Demand Recovery; Eyeing on New iPhone Launch
23
Feb
2021
Optics: Lighting up the world, looking into the future
03
Sep
2021
Ming Yuan Cloud (909.HK): solid growth in SaaS, near-term pressure on OPM
11
Sep
2020
A Little Thing of Tech Correction
03
Sep
2021
Nayuki (2150.HK): Fierce market competition leading to strong uncertainty in profitability
03
Dec
2021
Daily Chart: How much can the proportion of renewable energy consumption increase from 2018 to 2050?
10
Sep
2020
Tongcheng-elong: Clear visibility in recovery, upgrade to BUY rating
11
Feb
2021
SPDBI Global Central Banks Watch:Changing
02
Sep
2021
Everest Medicines (1952.HK):Approaching commercialization, potential 2-3 more in-licensing drugs by year end
09
Sep
2020
China's August Macro Data: Food prices drive down the CPI, while the economic recovery narrows the PPI decline
02
Sep
2021
Kuaishou (1024.HK): Improving revenue structure with attractive valuation; upgrade to BUY rating
02
Dec
2021
Daily Chart: Analysis of current US CPI inflation
07
Sep
2020
China's August Macro Data: The recovery in exports and imports has yet to peak
11
Feb
2021
China's January Macro Data: Slowing growth in aggregate financing, high-base effect and CPI rotation drive inflation down
01
Sep
2021
China's August Macro Data: China's epidemic rebound hits the service sector significantly, the overall economy has temporarily contracted
04
Sep
2020
“What's Past is Prologue”; Flavoring Sector 1H20 Review
31
Aug
2021
Smartphone Supply Chain 2Q21 Earnings Review: Strong Sell-in, but Weak Sell-through in 1H21; Being Cautious in 2H21, Preparing for 2021 Growth
01
Dec
2021
Daily Chart: Market Size and Supplier Breakdown of LiDAR for Automotive and Industrial Applications
01
Sep
2020
SPDBI Global Central Banks Watch:New Monetary Policy Framework has Hints of Long-Term Easing
06
Feb
2021
PA Good Doctor (1833.HK) 2020 earnings: higher than expected growth, online medical services maintained robust growth
31
Aug
2021
Pharmaron(3759.HK/300759.CH):1H21 results: Key segments maintain robust growth, enhancing CRO/CDMO one-stop solution capabilities through M&A
01
Sep
2020
Chinese Smartphone OEMs Conquering the World
30
Aug
2021
Remegen(9995.HK):Key drugs sales ramping up, RC 48 licensed-out proves pipeline competiveness
30
Nov
2021
Daily Chart: Camera Module October Shipment Comparison: Sunny vs Q-Tech
31
Aug
2020
China's August Macro Data: A sustained rebound in PMI led by the recovery of non-manufacturing business activities
05
Feb
2021
Alibaba (9988.HK): Solid 3Q results with cloud turning profitable
30
Aug
2021
Kingsoft (3888.HK): New games delayed; revenue guidance tuned down
28
Aug
2020
Pharmaron 1H20 Earnings: Robust Growth With Margin Expansion
27
Aug
2021
Ping An Health(1833.HK)1H21 results: Strategy upgrade continues; maintains guidance of profit making in 2024-25E
29
Nov
2021
Daily Chart: China’s major internet companies’ revenue growth slows down in 3Q21
28
Aug
2020
Meituan Dianping 2Q20 Earnings: Strong Beat on Delivery Earnings
04
Feb
2021
Don't Sweat the Liquidity Squeeze
26
Aug
2021
Remain cautious on risk assets amid the approaching QE tapering
28
Aug
2020
Fed’s Dovish Monetary Framework and Its Implications for Asset
26
Aug
2021
SEA (SE US): Solid growth across all segments
29
Nov
2021
Omicron variant adds uncertainties to global pandemic
27
Aug
2020
The United Lab 1H20 Earnings: Robust Growth of Insulin Products
04
Feb
2021
TOT Biopharm (1875.HK): IND application of TAB014 Phase III Clinical Trial authorized by FDA
25
Aug
2021
Tongcheng-Elong (780.HK): New record in users with improving GPM
27
Aug
2020
Alibaba 1QFY21 Earnings: A Strong Quarter with Solid Growth
25
Aug
2021
Anta (2020.HK): 1H21 results slightly better than expected; long-term growing logic still holds despite short-term headwind in 2H21
26
Nov
2021
Daily Chart: China’s oncology drug market may grow at a 2020-25E CAGR of 16%, outpacing the global market
27
Aug
2020
China's July Macro Data: Industrial Profits Keep Rising
02
Feb
2021
Transsion (688036.CH): Strong earnings growth in 4Q20
25
Aug
2021
Yonyou Network (600588.CH): Strong growth momentum in cloud business
27
Aug
2020
Genertec Universal Medical 1H20 Earnings: Recovered from Covid-19 Gradually
25
Aug
2021
Wuxi Biologics(2269.HK):1H21 result beats,higher revenue contribution from CMO and COVID projects going forward
25
Nov
2021
Kuaishou (1024.HK): Better-than-expected 3Q result with healthy user growth
26
Aug
2020
Kintor Pharma 1H20 earnings: NDA filing for Proxalutamide in China is expected in 4Q20
02
Feb
2021
Wingtech (600745.CH): 4Q20 earnings missing expectation; maintaining positive view on long-term growth
25
Aug
2021
Kingdee (268.HK): Better-than-expected topline growth with increasing loss
24
Aug
2020
The Story Just Unfolds; Look into Yihai from Three Perspectives
25
Aug
2021
China's July Macro Data: China's economy hits short-term headwinds, delaying the double-engine recovery
25
Nov
2021
Daily Chart: Peaking of premium Baijiu’s first-tier wholesale price in the short-term
24
Aug
2020
Scholar Education 1H20 earnings: Further expansion in Greater Bay Area
02
Feb
2021
China's January Macro Data: Stabilizing manufacturing sector awaits new drivers, services sector cools amid a resurgence of COVID-19
20
Aug
2021
Tencent (700.HK): inline 2Q result, regulation headwind ahead
21
Aug
2020
Ascentage Pharma: Submitted NDA for core product HQP1351 in China
20
Aug
2021
Zhaoke Ophthalmology(6622 HK) 1H21 results: Phase III of cyclosporine A ophthalmic gel met primary endpoint, key clinical trials on track
24
Nov
2021
Daily Chart: Global assets under management exceeded one hundred trillion, and the proportion of passive products increased
19
Aug
2020
WuXi AppTec: Fast recovered; Big changes in paper gains from investment
01
Feb
2021
PA GOODDOCTOR (1833.HK) earnings preview: Strategy upgrade in progress
18
Aug
2021
Weimob (2013.HK): Solid growth in SaaS business
19
Aug
2020
WuXi Biologics 1H20 results: Beat consensus due to COVID-19 projects
17
Aug
2021
The approaching QE tapering—SPDBI Global Central Banks Watch
19
Aug
2020
Kingsoft: Solid 2Q Result with 30%+ FY20 Topline Guidance
29
Jan
2021
Wuxi AppTec (2359.HK) Earnings Preview: Strong net profit growth beats consensus
17
Aug
2021
Pou Sheng (3813.HK): 1H21 NP beat; higher certainty in 2021 full-year margin improvement despite short-term pressure on sales
19
Aug
2020
Read on US Further Restriction on Huawei
17
Aug
2021
Baidu (9888.HK): AI cloud maintained rapid growth; 3Q guidance lower than expected
24
Nov
2021
Alibaba(9988HK\BABA.US):FY22 guidance turned down on weak E-commerce growth
18
Aug
2020
TOT Biopharm 1H20 results: ADC drug entered phase III trial, biosimilar NDA submission delayed
28
Jan
2021
China’s December Macro Data: Industrial efficiency sees an overall improvement, and inventory growth is set to accelerate
17
Aug
2021
TOT Biopharm(1875.HK)1H21 results:robust CDMO,TAA013 Phase III clinical trials on schedule
18
Aug
2020
Smartphone Optics Industry: Sunny and Q-Tech 1H20 Earnings Slightly Beating Market Expectation
17
Aug
2021
Li Ning (2331.HK): Actual 1H21 results stronger than profit alert; 2H21 guidance better than expected
24
Nov
2021
Bilibili (9626.HK\BILI.US):Better-than-expected user growth along with increasing loss
14
Aug
2020
China's July Macro Data: Steady Recovery Amid Flood
28
Jan
2021
Zai Lab (9688.HK):Zejula® included in China’s NRDL, while pipeline expanded with three new license-in assets
17
Aug
2021
Wuxi Apptec(603259.CH、2359.HK)1H21 results: strong growth in CDMO, global demand continues to be robust
14
Aug
2020
Uni-President (220 HK) Nudges “Kai Xiao Zao”
13
Aug
2021
Smartphone Optics Tracker: Smartphone Peak Season Boosting Sequential Growth in July, but YoY Momentum Remaining to be Monitored
24
Nov
2021
Short-term investment strategy: Bilibili (9626.HK) to rebound from oversold
13
Aug
2020
Gold is Not Golden
26
Jan
2021
Wuxi Biologics (2269. HK): More COVID-19 projects and acceleration in capacity expansion
13
Aug
2021
The first licensed-out ADC: Seagen licenses RemeGen (9995.HK)’s disitamab vedotin
12
Aug
2020
Smartphone Optics Tracker: Domestic Smartphone Demand Weakening, but Samsung Overseas Demand Recovery Supporting Sunny’s Continuous Growth
13
Aug
2021
Zai Lab(9688.HK) 1H21 results: Revenue growth beats; Zejula recorded strong growth after inclusion in NRDL
07
Aug
2020
China's July Macro Data: Ongoing Recovery in Imports and Exports
19
Jan
2021
SPDBI Research: Termination of Coverage (2021-01-19)
13
Aug
2021
China Youzan (8083.HK): GMV growth slower than expected, downgrade to neutral
07
Aug
2020
IGG:Turnaround
05
Aug
2021
Alibaba (9988.HK/BABA.US): Decent growth in core business, Aliyun slow down
24
Nov
2021
Time of taper is confirmed——SPDBI Global Central Bank Watch
04
Aug
2020
Inke (3700. HK): SNS, the new growth driver
19
Jan
2021
iDreamSky (1119. HK): Deeper cooperation with Tencent in entertainment
04
Aug
2021
Short-term Investment Strategy Termination: WuXi AppTec (2359.HK)
31
Jul
2020
China's July Macro Data: Manufacturing PMI rises to Two-year High
03
Aug
2021
China's July Macro Data: China’s economic expansion marginally slowed down due to the chain reaction and exogenous shock
31
Jul
2020
SPDBI Global Central Banks Watch:Further Accommodation, Strong EUR Not Sustainable
19
Jan
2021
Short-term Investment Strategy Termination: Xiaomi (1810. HK)
02
Aug
2021
Trillion RMB sector allocation
31
Jul
2020
Ali-Empire, Rock Solid
30
Jul
2021
Short-term Investment Strategy Termination: Everest Medicines (1952.HK)
19
Nov
2021
Daily Chart: Smartphone brand loyalty of Apple, Samsung, and Google in US
30
Jul
2020
A Glance at 2020 New Sugar-Free Beverages, a Rising Trend
19
Jan
2021
Strategist ’s commentary: A surge in southbound flows
30
Jul
2021
Short-term Investment Strategy Termination: WuXi Biologics (2269.HK)
28
Jul
2020
China’s June Macro Data: Industrial Profits
30
Jul
2021
Short-term Investment Strategy Termination: Li Ning (2331.HK)
18
Nov
2021
Daily Chart: Double 11 sales growth slows down in 2021
24
Jul
2020
CRO sector recovered to robust growth, positive long-term outlook
19
Jan
2021
China's December Macro Data: The manufacturing sector thrived and a consumption rebound to be expected
30
Jul
2021
Short-term Investment Strategy Termination: Pharmaron (3759.HK)
24
Jul
2020
Hang Seng TECH Index—Rising HK stock new power
28
Jul
2021
Short-term investment strategy: Everest Medicines (1952.HK) to rebound
18
Nov
2021
Ping An Health(1833.HK):Strategy upgrade adapts to market trends, but short-term pain is inevitable
17
Jul
2020
China’s June Macro Data: V-shaped Recovery Confirmed, What’s Next?
18
Jan
2021
Semiconductor Industry Tracker: A Revelation for 2021 from TSMC
28
Jul
2021
Short-term investment strategy: Zhaoke Ophthalmology (6622.HK) to rebound from oversold
16
Jul
2020
Hengan (1044 HK) Investor Meeting Highlights: Growth Driven by Premiumization and Online Sales ; to Raise Dividend Payout
28
Jul
2021
Short-term investment strategy: Pharmaron (3759.HK) to rebound from oversold
16
Jul
2020
Netdragon (777.HK) Takeaway: Dual drivers: “game + education”
18
Jan
2021
NEV Tracker: In December, China’s NEV Monthly Sales YoY Dropped from Peak, and Penetration Increased
28
Jul
2021
Short-term investment strategy: WuXi Biologics (2269.HK) to rebound from oversold
28
Jul
2020
Short-term investment strategy: WuXi AppTec (2359.HK) to rebound from oversold
17
Nov
2021
Daily Chart: Proportion of non-hospital drug sales steadily climbs
16
Jul
2020
Q-Tech (1478.HK) Takeaway: CCM ASP Increase Boosting Earnings to Grow
15
Jan
2021
Short-term investment strategy: Xiaomi (1810. HK) to rebound from oversold
28
Jul
2021
Li Ning(2331.HK): buy on dip
15
Jul
2020
Huawei 1H20 Earnings Read: 1H20 Consumer Business Better than Expectation, Smartphone Demand Softens into 3Q20
28
Jul
2021
Short-term investment strategy: Li Ning (2331.HK) to rebound from oversold
16
Nov
2021
Daily Chart: 2021 YTD price hike of major raw materials in China consumer space
14
Jul
2020
Smartphone Optics Tracker: Q-Tech Profit Alert Beats Market Expectation; Prefer Sunny over Largan in the Short-term
15
Jan
2021
China's December Macro Data: Slowing growth in aggregate financing and unsustainable rise in inflation will not affect the economic recovery driven by the manufacturing sector
23
Jul
2021
Akesobio (9926.HK): Penpulimab is expected to be approved this year; multiple milestones and catalysts of clinical progress ahead
10
Jul
2020
Largan 2Q20 Earning Takeaway: High-end Smartphone Weak Demand Continues Into Next Two Months
23
Jul
2021
Chinese Internet Stocks: Is the “darkest hour” over?
16
Nov
2021
China's October Macro Data: Industry production stabilized, investment hit bottom, and weak consumption recovery
09
Jul
2020
SPDBI Global Central Banks Watch 07/2020 Issue
12
Jan
2021
SPDBI Global Central Banks Watch:Most CBs are cautiously optimistic, except ECB
21
Jul
2021
China's June Macro Data: China's economic transition in 2Q21
08
Jul
2020
Tech IPO Track: MEMSensing: Domestic MEMS Rising on the Horizon
20
Jul
2021
Short-term investment strategy: Q Technology (1478.HK) to rebound from oversold
29
Jun
2020
Wuxi biologics: Short term impacted, long term growth intact
11
Jan
2021
Smartphone Optics Tracker: Supply Chain Shortage Impacting Monthly Performance
19
Jul
2021
New Energy Vehicle and Smartphone Industry and Supply Chain Comparison: The Initial Melee among New Forces, Smartphone Players, Internet Giants, and Traditional and Transformational Car Makers
26
Jun
2020
Sunny Optical Investor Day Takeaway: Macro Volatility Does Not Alter CCM Upgrade Trend
16
Jul
2021
Fed officials split on QE easing, PBoC enforced a RRR cut—SPDBI Global Central Banks Watch
15
Nov
2021
Daily Chart: Reasons for overseas investors to invest in China
19
Jun
2020
2H20 Outlook: What Doesn’t Kill You Makes You Stronger
08
Jan
2021
Optics Industry Track: Largan’s Implication on High End Lens Upgrade
15
Jul
2021
XPeng Motors (9868.HK) Initiation: Pioneer of Autonomous Driving Among NEV New Forces
19
Jun
2020
2H20 Technology Sector Outlook: Looking for Certainties among Uncertainties
14
Jul
2021
Smartphone Optics Tracker: 2Q21 Optics Companies Performance Dragged by Weak Smartphone Demand and CCM Spec Upgrade Speed Slowing Down in the Short-term
15
Nov
2021
3Q21 OPM significantly missed, leading to low possibility to meet 2021 full-year guidance with rising uncertainty; Downgrade to “Hold”
19
Jun
2020
2H20 Internet Sector Outlook: Clear visibility in “Return”
06
Jan
2021
Xiaomi (1810.HK): High Growth and High Certainty in 2021
09
Jul
2021
Quantification of US inflation risks based on demand-supply framework
19
Jun
2020
2H20 Healthcare Sector Outlook: Looking for Long-term Opportunities Amid Dispersion
15
Nov
2021
China's October Macro Data: PPI at Record High while CPI Picking Up; Financial Conditions are Yet to Loosen Up but Loan Growth Rebounded
19
Jun
2020
2H20 Consumer Sector Outlook: Riding On Key Trends for Winners
21
Dec
2020
SaaS in sweet spot
09
Jul
2021
Five-Year retail sales growth target for Anta brand higher than expected, demonstrating mgmt’s strong confidence
19
Jun
2020
2H20 Strategy Outlook: Stay with Central Banks
07
Jul
2021
CDE’s proposed new rules for oncology drug trials: top players will be the beneficiaries, while subsectors with lofty valuations tumbled
12
Nov
2021
Daily Chart: Analyze the global supply chain crisis from the perspective of U.S. container ports
19
Jun
2020
2H20 Macro Outlook: Top 10 Post-Pandemic Q&A
19
Dec
2020
Biotech Report (1) : Antibody-drug Conjugates
07
Jul
2021
China Sportswear: New consumption trends and omni-channel fueling robust growth of leading China sportswear play
11
Jun
2020
Smartphone Optics Tracker: May Shipment Dragged by Overseas Pandemic, Supply Chain Recovery Pace Diversifies
02
Jul
2021
Short-term investment strategy: Li Auto Inc (LI.US) has upside potential in the short-term
11
Nov
2021
Daily Chart: NEV October Delivery of NIO, XPENG, Li Auto
10
Jun
2020
Meituan Dianping: All-Around Player in LBS
19
Dec
2020
Zai Lab (9688.HK): Integration and inclusive
02
Jul
2021
China's June Macro Data: resilient manufacturing and lower recovery expectations in service sector
07
Jun
2020
What Do We Learn from the Surprisingly Strong US Nonfarm Payrolls in May?
29
Jun
2021
New Covid-19 cases in Guangdong and diverged industrial enterprises’ profit data impede double-engine recovery
11
Nov
2021
Smartphone Optics Tracker: October Shipment Below Expectation and Limited Demand Improvement in 4Q21, but Timing to Invest into 2022.
05
Jun
2020
SPDBI Global Central Banks Watch 06/2020 Issue
14
Dec
2020
New Energy Vehicle Investment Handbook: Standing at the Starting Point of a Golden Decade, to Buy or Not to Buy?
29
Jun
2021
Zhaoke Ophthalmology (6622. HK): A rising star in ophthalmology
04
Jun
2020
Portfolio Strategy Series (1): High Correlation, High Dispersion, So What?
25
Jun
2021
The fifth batch of national GPO results released, impact gradually turn to positive to pharma companies (attached analysis of H-listed pharma companies market share)
10
Nov
2021
Daily Chart: 3Q21 Global Smartphone Shipments Declined 7% Year Over Year
20
May
2020
Bilibili: Strong User Growth Momentum Coupled With Increasing Loss; 2Q Guidance Beat
08
Dec
2020
2021 Outlook: Navigating Through the New Normal
25
Jun
2021
New Energy Vehicle Investment Handbook: The Beginning of a Golden Decade, from Sell to Buy, Riding on Valuation Digestion and Fundamental Growth
14
May
2020
Tencent: 1Q Earnings Strong Beat on Mobile Games and Social Advertisement
18
Jun
2021
Immunotech Biopharm (6978.HK): Focusing on cellular immunotherapy, EAL is expected to launch in the near future
09
Nov
2021
Daily Chart: Livestreaming has become an important marketing method in E-Commerce industry
13
May
2020
Initial Read on Nongfu Spring: Premium, Profitable, Defensive; Future on New Product and M&A
08
Dec
2020
2021 Healthcare Sector Outlook: Insist on innovation, active waiting
18
Jun
2021
We are about to see a “Good news is bad news” pattern driven by the US job statistics—SPDBI Global Central Banks Watch
07
May
2020
Pharmaron: Raising Target Price on Resilient 1Q Earnings
07
Jun
2021
2H21 Outlook: Seizing the structural opportunities
08
Nov
2021
China's October Macro Data: China's exports continued to expand and the trade surplus hit a single-month record high
06
May
2020
Tongcheng-Elong: Expect Moderate Tourism Recovery
08
Dec
2020
2021 Strategy Outlook: From Up to Down, From Macro to Micro
07
Jun
2021
2H21 Macro Outlook: It’s the quality of growth that matters
06
May
2020
WuXi AppTec: Limited COVID-19 Impact on Full Year Earnings
07
Jun
2021
Maneuver through the Peak with Caution
08
Nov
2021
Daily Chart: Flourishing Chinese surgical robot market
05
May
2020
SPDBI Global Central Banks Watch May 2020 Issue
08
Dec
2020
2021 Macro Outlook: A New Decade, a Disparate Decade
07
Jun
2021
2H21 Healthcare Sector Outlook: Review and thinking on the plateau
28
Apr
2020
Sinopharm: Better-than-expected 1Q Results
07
Jun
2021
2H21 Technology Sector Outlook: Looking for Opportunities Amid Smartphone Demand Volatility and Semiconductor Capacity Shortage
27
Apr
2020
Haitian: Resilient 1Q20 results aided by Penetration and Optimization
08
Dec
2020
2021 Consumer Sector Outlook: Leverage Category Dividend, Rewrite Industry Rankings
07
Jun
2021
2H21 Internet Sector Outlook: Investment opportunities along with regulatory risk
23
Apr
2020
Avastin biosimilar TAB008 Pusintin met the primary endpoint in Phase III trial
07
Jun
2021
2H21 Consumer Sector Outlook: Four structural consumption trends in post-COVID era
05
Nov
2021
Daily Chart: Why is it necessary for China consumer companies to transform from wholesale to DTC?
22
Apr
2020
CRO/CDMO:More Upside to Come
08
Dec
2020
2021 Technology Sector Outlook: End Demand Recovering and Rising, Opportunity Among Competitive Landscape Reshaping
04
Jun
2021
Weimob (2013.HK):Completed placement of US$ 600 million in new shares and convertible
22
Apr
2020
Where does the US Market Rebound Lead Us To?
04
Jun
2021
Kingsoft (3888.HK): Software business still solid, decent growth in flagship title
04
Nov
2021
Daily Chart: The market selection of individual fund investors usually leads to "time to loss is more " and "money earn from win is less"
17
Apr
2020
Does the Rebound in China’s Macro Data Confirm Bottoming Out?
08
Dec
2020
2021 Technology Sector Outlook: The New Digital Era
04
Jun
2021
Tongcheng-Elong (780.HK): solid recovery in domestic tourism, raise TP to HK$24
09
Apr
2020
SPDBI Global Central Banks Watch
01
Jun
2021
Ali Health (241.HK): Lower than expected growth rate amid negative market sentiment
03
Nov
2021
Daily Chart: Inflation and unemployment - two challenges that G20 countries face
03
Apr
2020
How to Fish at the Bottom?
04
Dec
2020
Xiaomi (1810. HK): Read on Placement and CB
31
May
2021
The “four quadrants” approach: A new method of analyzing market consensus and divergence
27
Mar
2020
Buckle Up:The Risk and Opportunities amidst Global Recession
28
May
2021
Smartphone OEM and Supply Chain: 1Q21 Strong Earning Results and 2Q21 Soft Demand Does Not Alter 2021 Recovery Trend
02
Nov
2021
Wuxi Apptec(603259.CH、2359.HK)3Q21 results:High growth in core businesses,CAPEX to accelerate
24
Mar
2020
Top 10 Industry Trends Reinforced by the Pandemic
27
Nov
2020
China Beverage Industry Initiation: It is a Marathon, Not a Sprint
27
May
2021
China equities valuation handbook